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  in	  part,	  the	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  of	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   that	   confer	   the	   ability	   to	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   Herein	  we	   describe	   efforts	   to	  reconstitute	  parts	  of	  the	  Escherichia	  coli	  cell	  division	  machinery	  inside	  of	  water-­‐in-­‐oil	  emulsion	  compartments	  and	  synthetic	  phospholipid	  vesicles.	   	  The	  system	  was	  built	  with	  DNA	  and	  purified	  transcription	  and	  translation	  machinery	  housed	  in	   a	   compartment.	   	   A	   particular	   emphasis	   was	   placed	   on	   FtsZ,	   a	   protein	   that	  oligomerizes	  into	  a	  ring	  at	  the	  midcell	  and	  splits	  the	  cell	  into	  two.	  	  FtsZ	  does	  not	  contain	   a	   membrane	   interaction	   domain.	   	   In	   vivo,	   FtsZ	   interactions	   with	   the	  membrane	  are	  mediated	  by	  FtsA	  and	  ZipA.	   	  Therefore,	   the	   influence	  of	  FtsA	  on	  the	  behavior	  of	  FtsZ	  also	  was	  investigated.	  	  Fluorescently	  tagged	  constructs	  were	  used	  to	   facilitate	  evaluation	  by	  microscopy.	   	  The	  data	  showed	  that	  FtsZ	  readily	  assembles	   into	   rings	   in	   the	   presence	   of	   FtsA,	   thereby	   suggesting	   that	   the	   Fts	  system	  can	  be	  exploited	  for	  building	  a	  genetically	  encoded,	  self-­‐replicating,	  cell-­‐like	   system.	   We	   also	   explored	   additional	   methods	   of	   dividing	   compartments,	  such	  as	  the	  use	  of	  aqueous	  two	  and	  three	  phase	  systems.	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  1	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1.Introduction	  	  	   	  	  	   Projects	  that	  fall	  within	  the	  “Synthetic	  Biology	  Space”	  either	  construct	  in	  
vivo	  or	   in	   vitro	   living	   or	   life-­‐like	   systems.1,2,3.	  In	   other	  words,	   synthetic	   biology	  deals	  with	   life	  or	   tries	   to	  mimic	   it.	  Those	  that	  are	  engaged	  with	   in	  vivo	   studies,	  engineer	   biomolecules	   and	   genomes	   and	   implement	   them	   in	   extant	   cells	   or	  organisms	  follow	  a	  “top	  down	  strategy”4.	  On	  the	  other	  hand,	  synthetic	  biologists	  that	   decide	   to	   face	   in	   vitro	   studies,	   design	   biomolecules	   and	   genomes	   for	   the	  generation	  of	  synthetic	  cells	  from	  scratch	  embrace	  a	  “bottom	  up	  strategy”.5	  	  	   Two	  frequent	   terms	  encountered	   in	  synthetic	  biology	  are	  “minimal”	  and	  “artificial”.	  	  A	  minimal	  cell	  is	  a	  cell	  that	  has	  the	  minimal	  requirements	  and	  parts	  to	   be	   considered	   alive.	   	   An	   artificial	   cell	   is	  made	   from	   artificial	   components6-­‐8.	  Whatever	  could	  be	  the	  design	  of	   the	  de	  novo	   cell,	   the	  synthetic	  biologist,	  as	   the	  word	   synthesis	   from	   the	   ancient	   Greek	   σύνθεσις	   (putting	   together)	   suggests,	  will	   put	   together	   well	   characterized	   biological	   parts	   and	   assemble	   them	   in	  different	  ways	  in	  order	  to	  obtain	  desired	  function.	  The	  biological	  parts	  are	  like	  a	  defined	  set	  of	  Lego	  bricks	  that	  could	  be	  assembled	  in	  different	  ways	  in	  order	  to	  get	  different	  functions	  (Fig	  1).	  	  The	   most	   attractive	   and	   desired	   functionality	   to	   be	   reproduced	   in	   a	  synthetic	  cell	  are	  functions	  that	  mimic	  key	  properties	  of	  life.	  In	  this	  experimental	  work	  we	  embraced	  a	  “bottom	  up	  strategy”	  aimed	  at	  mimicking	  a	  key	  feature	  of	  life,	   that	   of	   cellular	   replication.	   We	   assembled	   components	   of	   the	   division	  machinery	  system	  of	  E.	  coli	   reconstituting	   in	  a	   first	  step,	  with	  purified	  proteins	  and	   then	  with	  DNA	  and	  purified	   transcription	   translation	  machinery	  housed	   in	  phospholipid	   vesicles	   and	   water-­‐oil	   (w/o)	   emulsions.	   Further,	   we	   developed	  new	   compartments	   for	   the	   potential	   localization	   and	   topography	   of	   our	  genetically	  encoded	  system.	  In	   chapter	   one	   an	   overview	   of	   our	   “synthetic	   minimal	   cell”	   (Fig.1.2)	  synthesized	  from	  the	  bottom	  up	  is	  presented.	  Herein	  we	  will	  describe	  a	  model	  of	  
	  	   2	  
cell	  replication,	  the	  genetically	  encoded	  system	  for	  the	  proteins	  FtsZ	  and	  FtsA	  (E.	  
coli	   cell	   division	   proteins),	   the	   compartments	   used	   (phospholipid	   vesicles	   and	  water-­‐oil	   emulsions),	   and	   finally	   a	   cytoplasm-­‐like	   model	   (ATPS	   in	   water-­‐oil	  emulsions).	  	  	  	  	  	  
	  	  Fig.1:	  The	  desire	  of	  the	  synthetic	  biologist.	  Defined	  parts	  assembled	  in	  different	  	  ways,	  for	  different	  desired	  functionality.	  Retrieved	  from	  Wikimedia.	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Fig.	  1.2	  :	  	  An	  overview	  of	  	  the	  synthetic	  minimal	  cell	  assembled	  from	  the	  bottom-­‐up.	  The	  aim	  is	  to	  reconstitute	  in	  	  cell-­‐like	  compartments	  a	  transcription	  and	  translation	  system	  for	  the	  production	  of	  a	  minimal	  division	  machinery	  ,	  made	  of	  FtsZ	  and	  FtsA.	  The	  system	  is	  assembled	  from	  the	  scratch,	  starting	  from	  simple	  chemical	  molecules	  such	  as	  nucleotides,	  amino	  acids	  and	  simple	  biomolecules	  as	  ribosomes,	  tRNAs	  and	  enzymes.	  The	  surplus	  value	  is	  represented	  by	  the	  fact	  that	  has	  also	  an	  internal	  compartmentalization,	  obtained	  by	  the	  addition	  of	  polymers.	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  1.1	  E.	  coli	  cell	  division	  is	  an	  excellent	  model	  of	  cell	  replication.	  	  	   There	  is	  no	  life	  without	  replication	  and	  without	  replication	  there	  is	  no	  evolution.	  Our	  aim	  is	  to	  mimic	  replication,	  both	  DNA	  replication	  and	  cell	  body	  division	  for	  a	  better	  comprehension	  of	  life	  and	  its	  diversity.	  We	  use	  E.	  coli	  as	  our	  cell	  model	  system.	  	   Cell	   division	   in	   E.	   coli,	   as	   in	   other	   bacterial	   cells,	   is	   driven	   by	   the	  divisome8-­‐9	   a	   multi	   protein	   machinery	   system	   (Fig.1.3).	   	   The	   machinery	   is	  composed	   of	   a	   dozen	   proteins	   and	   among	   these,	   a	   protein	   called	   FtsZ	  (filamentous	  thermo	  sensitive	  protein)	  plays	  a	  pivotal	  role.	   	  FtsZ	  is	  a	  structural	  homologue	   of	   the	   eukaryotic	   protein	   tubulin10,11	   and	   undergoes	   a	   GTP-­‐dependent	  self-­‐assembly	  into	  polymers	  which	  form	  the	  Z	  ring.	  The	  Z	  ring	  has	  a	  dynamic	   structure	   that	   generates	   a	   constriction	   force	  necessary	   for	   the	   cell	   to	  divide	   and	   serves	   as	   a	   scaffold	   for	   the	   recruitment	   of	   the	   downstream	  components	  of	  the	  divisome.	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  Fig1.3:	  The	  Divisome	  of	  E.	  coli	  is	  a	  multi	  protein	  machinery	  system,	  composed	  by	  a	  dozen	  of	  proteins	  participating	  to	  the	  process	  of	  cell	  division.	  Between	  these	  proteins	  FtsZ	  and	  FtsA	  are	  playing	  a	  pivotal	  role.	  Vicente	  et	  al.,	  EMBO	  reports	  4,	  655–60	  (2003).	  	  	   	  The	  process	  of	  cytokinesis	  in	  E.	  coli	  requires	  some	  proteins	  and	  some	  events	  to	  occur.	  Cytokinesis	  occurs	  after	  chromosome	  replication	  and	  segregation.	  The	  Z	  ring	  is	  localized	  at	  the	  midpoint	  of	  the	  rod,	  perpendicular	  to	  the	  long	  axis	  of	  the	  cell.	  This	  specific	  positioning	  of	  the	  ring	  permits	  the	  division	  of	  the	  cell	  in	  two	  daughter	  cells	  (Fig	  1.4).	  A	  precision	  so	  strict	  is	  guaranteed	  by	  the	  synergistic	  action	  of	  two	  protein	  systems	  able	  to	  spatially	  regulate	  the	  cell	  division:	  the	  Noc	  system	  and	  the	  Min	  system.	  The	  Noc	  system13,	  inhibits	  division	  in	  the	  vicinity	  of	  the	  chromosome	  (the	  nucleoid),	  ensuring	  that	  chromosomes	  are	  not	  bisected	  by	  the	  septum.	  The	  Min	  system	  prevents	  the	  formation	  of	  the	  Z	  ring	  at	  the	  cell	  poles	  and	  avoids	  the	  potential	  formation	  of	  DNA	  minicells14.	  	  	  
















Fig.	  1.4:	  E.	  coli	  cell	  division.	  After	  replication	  of	  the	  chromosome,	  the	  Z	  ring,	  formed	  by	  	  	  FtsZ	  polymerization,	   divides	   the	   cell	   in	   two	   exactly	   identical	   daughter	   cells.	   The	   strict	  positioning	  of	   the	   ring	   is	   guaranteed	  by	   the	  Noc	   system	  and	   the	  Min	   system.	  The	  Noc	  system	   avoids	   cell	   division	   in	   proximity	   of	   the	   chromosome,	   the	   Min	   system	   in	   the	  proximity	  of	  the	  cell	  poles.	  	  	   The	  Min	  system	  is	  composed	  of	  MinC,	  MinD	  and	  MinE.	  	  MinC	  is	  the	  direct	  inhibitor	  of	  FtsZ	  polymerization	  and	  binds	  MinE	  that	  interacts	  with	  MinD,	  an	  ATPase	  membrane	  protein.	  MinE	  moves	  MinD	  from	  the	  cell	  poles	  to	  the	  middle	  of	  the	  rod,	  hydrolyzing	  the	  ATP	  bound	  to	  MinD.	  Min	  E	  is	  the	  protein	  responsible	  of	  the	  oscillation	  that	  regulates	  the	  positioning	  of	  the	  Z	  ring	  in	  the	  middle	  of	  the	  cell.	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1.2	  The	  keystones	  of	  the	  divisome:	  FtsZ,	  ZipA	  and	  FtsA	  	  The	  spatial	  disposition	  of	  the	  Z	  ring	  is	  controlled	  by	  the	  Min	  and	  the	  Noc	  system,	  but	  the	  ring	  needs	  to	  be	  tethered	  to	  the	  membrane	  in	  order	  to	  generate	  the	  constriction	  force	  for	  cell	  division.	  FtsA	  and	  ZipA	  tether	  the	  Z	  ring	  to	  the	  membrane	  and	  in	  combination	  with	  FtsZ	  are	  considered	  the	  proto-­‐ring	  elements.	  	  ZipA	  is	  a	  trans-­‐membrane	  protein,	  which	  tethers	  the	  Z	  ring	  to	  the	  membrane	  through	  interactions	  between	  its	  C	  terminus	  and	  the	  conserved	  C-­‐terminal	  tail	  of	  FtsZ,	  made	  of	  10	  amino	  acids	  (DYLDIPAFLR)	  15..	  Given	  the	  role	  of	  ZipA	  in	  Z	  ring	  tethering,	  it	  has	  been	  shown	  that	  a	  gain	  of	  function	  point	  mutation	  in	  FtsA	  (R286WFtsA)	  16	  can	  render	  E.	  coli	  independent	  of	  ZipA.	  Therefore,	  it	  appears	  that	  FtsA	  is	  the	  primary	  tether	  of	  the	  Z	  ring	  to	  the	  membrane.	  	  FtsA	  is	  a	  homologue	  of	  the	  eukaryotic	  actin17-­‐	  18	  and	  interacts	  with	  the	  membrane	  through	  an	  amphipathic	  helix	  of	  15	  amino	  acids	  (GSWIKRLVSWLRKEF)	  present	  at	  the	  C	  -­‐terminus	  of	  the	  protein	  sequence.	  The	  ratio	  of	  FtsA	  versus	  FtsZ,	  plays	  a	  crucial	  role	  in	  cell	  division. This	  ratio	  is	  roughly	  1:5,	  with	  approximately	  700	  molecules	  of	  FtsA	  and	  3200	  molecules	  of	  FtsZ	  per	  cell19.	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  1.3	  Reconstitution	  of	  minimal	  cell	  division	  machinery	  in	  vitro.	  	  	  To	  date	  it	  is	  possible	  to	  model	  simpler	  division	  systems	  in	  vitro	  despite	  the	  redundancy	  of	  the	  divisome	  and	  complexity	  of	  division	  in	  vivo.	  	  The	  imitation	  in	  
vitro	  of	  cell	  replication	  focuses	  on	  two	  main	  aspects,	  the	  reconstitution	  of	  a	  minimal	  divisome	  and	  the	  development	  of	  cell-­‐like	  compartments	  able	  to	  mimic	  the	  physicochemical	  but	  also	  mechanical	  process	  of	  division.	  	   There	  are	  marvelous	  examples	  of	  bottom-­‐up	  reconstitution	  of	  minimal	  cell	  division	  machinery	  in	  vitro.	  Erickson	  and	  colleagues	  engineered	  FtsZ-­‐YFP-­‐MinD,	  a	  modified	  version	  of	  FtsZ	  ,	  able	  to	  insert	  directly	  into	  the	  membrane	  of	  multilamellar	  liposomes20-­‐21.	  This	  version	  of	  FtZ	  is	  able	  to	  polymerize	  and	  to	  form	  Z-­‐rings	  in	  tubular	  liposomes,	  causing	  indentations	  within	  the	  membranes.	  The	  Min	  protein	  system	  was	  reconstituted	  on	  supported	  lipid	  bilayers,	  generating	  protein	  waves,	  correspondent	  to	  the	  oscillation	  produced	  in	  vivo22	  and	  proto	  ring	  elements	  (FtsZ,	  FtsA	  and	  ZipA)	  of	  the	  Divisome	  were	  assembled	  in	  Giant	  Vesicles	  (GVs)	  23(Fig	  1.5).	  	  	  	  
	  	   Fig.	  1-­‐5: Structure of a Giant Vesicle having one lipid bilayer (unilamellar). 
Reprinted with	  permission from Menger and Angelova, Acc. Chem. Res. 1998, 31, 789-797. 
Copyright 1998American Chemical Society.	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The	  design	  of	  minimal	  models	  does	  not	  take	  in	  account	  that	  replication	  is	  also	  a	  physicochemical	  process.	  There	  are	  several	  examples	  of	  vesicle	  division	  mechanisms	  that	  do	  not	  rely	  on	  protein	  activity	  and	  were	  built	  in	  vitro.	  Membranes	  composed	  of	  three	  different	  lipids	  that	  phase	  separate	  into	  liquid	  ordered	  and	  disordered	  domains	  result	  in	  membrane	  curvature,	  budding	  and	  division	  by	  osmotic	  pressures24.	  While	  GVs	  with	  an	  encapsulated	  aqueous	  two	  phase	  system	  have	  budding	  morphology	  that	  undergo	  division	  in	  hypertonic	  solution.	  In	  both	  cases	  there	  is	  a	  single	  cycle	  of	  division,	  because	  the	  asymmetries	  are	  not	  retained	  in	  the	  daughter	  vesicles	  25-­‐26.	  The	  combination	  of	  liquid	  ordered	  and	  disordered	  domains	  and	  the	  encapsulation	  of	  ATPS	  in	  GVs	  allow	  a	  second	  cycle27.	  In	  the	  Sugawara	  laboratory	  an	  alternative	  pathway	  was	  developed	  that	  uses	  DNA	  replication	  to	  drive	  vesicle	  division28.	  A	  cationic	  composition	  of	  the	  lipid	  membranes	  is	  combined	  with	  the	  replication	  of	  the	  DNA	  by	  PCR	  and	  then	  ionic	  interactions	  between	  the	  lipids	  and	  the	  DNA	  result	  in	  vesicle	  division.	  This	  system	  combines	  two	  processes	  crucial	  for	  the	  construction	  of	  cellular	  life,	  genomic	  replication	  and	  compartment	  division.	  In	  our	  system	  we	  privilege	  the	  feature	  of	  compartment	  division.	  	   Our	  plan	  was	  to	  synthesize	  a	  genetically	  encoded	  minimal	  divisome	  with	  a	  cell-­‐free	  system	  in	  multi-­‐compartmentalized,	  cell-­‐like	  compartments	  containing	  aqueous	  two-­‐phase	  systems.	  	  	  	  1.4	  Cell	  free-­‐systems	  for	  protein	  synthesis.	  	  Cell-­‐free	  systems	  are	  our	  toolbox	  for	  the	  synthesis	  of	  a	  minimal	  synthetic	  cell.	  We	  worked	  with	  transcription	  translation	  systems	  from	  cellular	  extracts	  and	  purified	  T/T	  as	  the	  PURESYSTEM.	  	  	   We	  have	  availability	  of	  several	  sources	  for	  cell-­‐free	  transcription-­‐translation	  systems	  consisting	  of	  cell	  extracts	  from	  Escherichia	  coli	  (ECE),	  rabbit	  reticulocytes	  (RRL),	  wheat	  germ	  (WGE),	  and	  insect	  cells	  (ICE)	  29.	  Since	  these	  cells	  behave	  very	  differently,	  the	  extracts	  derived	  from	  them	  do	  as	  well.	  In	  general	  the	  choice	  of	  which	  kind	  of	  cellular	  extract	  is	  used	  is	  dictated	  by	  the	  kind	  of	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biologically	  active	  protein	  that	  has	  to	  be	  produced.	  The	  factors	  to	  be	  considered	  are,	  of	  course,	  the	  yield	  of	  the	  protein	  needed,	  the	  origin	  and	  the	  complexity	  of	  the	  protein,	  the	  cost,	  and	  the	  downstream	  processing	  necessary30.	  Proteins	  for	  our	  minimal	  cell	  division	  machinery	  system	  were	  produced	  by	  E.	  coli	  cell	  extract	  (Promega	  S30)	  supplied	  with	  a	  T7	  RNA	  polymerase	  or	  by	  fully	  purified	  transcription/translation	  (T/T)	  components	  from	  E.	  coli	  (PUREXPRESS®	  from	  NEB).	  	  	  	   The	  advantages	  of	  using	  a	  cellular	   lysate	  from	  E.	  coli	  is	   that	   it	  gives	  high	  yield	  of	  proteins,	   from	  hundreds	  of	  micrograms	  per	  milliliter	   to	  milligrams	  per	  milliliter	  in	  a	  batch	  reaction,	  depending	  on	  the	  protein	  of	  interest.	  Furthermore,	  in	  E.	  coli	  lysate	  are	  present	  factors	  that	  can	  help	  the	  folding	  of	  the	  proteins.	  The	  disadvantage	  is	  the	  presence	  of	  nucleases,	  meaning	  that	  higher	  amounts	  of	  DNA	  and	  circular	  DNA	  are	  needed.	  An	  example	  of	  	  	  E.	  coli	  cell	  lysate	  for	  the	  expression	  of	  a	  minimal	  protein	  system	  in	  vesicles	  is	  the	  synthesis	  of	  the	  bacterial	  actin-­‐like	  proteins,	  MreB	  and	  MreC31.	  This	  example	  is	  significant	  because	  the	  synthesis	  of	  MreB	   and	   MreC	   within	   vesicles	   shows	   the	   possibility	   to	   co-­‐express	   different	  proteins	   at	   the	   same	   time	   in	   just	   one	   compartment	  using	   a	   cell-­‐free	   system	  as	  source	  of	  transcription	  and	  translation	  machinery.	  	   In	  contrast,	  using	  the	  PURESYSTEM	  (PURExpress®	  from	  NEB)	  we	  can	  count	  upon	  a	  system	  made	  of	  fully	  defined,	  purified	  components,	  of	  which	  we	  know	  exactly	  the	  composition.	  The	  PURESYSTEM32	  contains	  recombinant	  histidine-­‐tagged	  amino	  acyl	  tRNA	  synthetases,	  initiation	  factors,	  elongation	  factors,	  release	  factors,	  ribosome	  recycling	  factors,	  methionyl-­‐tRNA	  transformylase,	  70S	  ribosomes,	  amino	  acids,	  rNTPs,	  and	  tRNAs.	  The	  mixture	  additionally	  includes	  T7	  RNA	  polymerase,	  creatine	  kinase,	  myokinase,	  nucleoside-­‐di-­‐phosphate	  kinase,	  and	  pyrophosphatase.	  The	  PURESYSTEM	  is	  free	  of	  inhibitory	  substances	  such	  as	  nucleases,	  proteases,	  and	  enzymes	  that	  hydrolyze	  nucleotide	  triphosphate,	  so	  you	  can	  work	  with	  low	  quantity	  of	  DNA	  for	  a	  high	  level	  of	  expression.	  The	  PURESYSTEM	  has	  been	  successful	  for	  other	  groups,	  i.e.	  Yomo	  and	  colleagues	  used	  the	  PURESYSTEM	  for	  in	  vitro	  compartmentalization	  (IVC)	  in	  liposomes.	  33,34.	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1.5	  Cell-­‐like	  compartments:	  water-­‐in-­‐oil	  emulsion	  droplets	  and	  phospholipid	  vesicles.	  	  
 
 The	  cell-­‐like	  compartments	  used	  in	  the	  following	  experiments	  for	  the	  synthesis	  or	  reconstitution	  of	  a	  minimal	  divisome	  are	  water	  in	  oil	  emulsions	  (w/o	  emulsions)	  and	  phospholipid	  vesicles.	  	  W/o	  emulsions	  are	  heterogeneous	  systems,	  made	  of	  a	  disperdent	  phase	  (oil)	  and	  a	  dispersed	  phase	  (water).	  Water	  in	  oil	  emulsions	  have	  features	  of	  great	  stability,	  due	  to	  the	  presence	  of	  surfactants	  in	  their	  composition,	  and	  great	  efficiency	  of	  encapsulation.	  Emulsions	  droplets	  can	  be	  as	  small	  as	  bacteria,	  with	  diameters	  of	  1	  µm	  and	  volumes	  of	  less	  than	  a	  femtolitre,	  or	  can	  have	  droplets	  of	  diameters	  up	  to	  100	  µm	  and	  volumes	  of	  nearly	  1	  nanolitre.	  	  Their	  high	  capacity	  (>1010	  droplets	  in	  1	  mL	  of	  emulsion),	  the	  ease	  of	  preparation,	  and	  their	  high	  stability	  over	  a	  broad	  range	  of	  temperatures,	  pH	  and	  salt	  concentrations	  render	  w/o	  emulsion	  ideal	  for	  compartmentalizing	  biochemical	  and	  genetic	  reactions35.	  W/o	  emulsions	  have	  been	  used	  for	  a	  long	  time	  for	  direct	  in	  vitro	  evolution	  and	  recently	  as	  container	  for	  biochemical	  reactions.	  34,35,36	  	  	   Lipid	  vesicles	  are	  formed	  by	  self-­‐assembly	  and	  are	  composed	  of	  bilayer	  membranes	  surrounding	  an	  aqueous	  core.	  The	  membrane	  is	  composed	  of	  double	  chain	  amphiphiles,	  most	  notably	  glycerophospholipids,	  but	  can	  also	  contain	  cholesterol,	  integral	  membrane	  proteins,	  and	  ion	  channels.	  Vesicles	  spontaneously	  assembly	  in	  aqueous	  solution	  to	  form	  micron-­‐scale	  compartments.	  A	  myriad	  of	  molecules	  such	  as	  proteins,	  enzymes,	  and	  nucleic	  acids,	  as	  well	  as	  polymers,	  hydrogels,	  and	  small	  vesicles	  have	  been	  encapsulated	  during	  vesicle	  formation37-­‐39.	  Additionally,	  several	  types	  of	  biochemical	  reactions	  have	  been	  reconstituted	  inside	  of	  vesicles,	  including	  transcription	  and	  translation40.	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1.6	  Water-­‐	  oil	  emulsion	  Aqueous	  Two	  Phase	  System	  (ATPS).	  	   ATPS	  is	  a	  good	  imitation	  of	  the	  cytoplasm.	  	  In	  living	  cells	  the	  presence	  of	  the	  cytoplasm	  provides	  compartmentalization,	  macromolecular	  crowding	  and	  small	  volume	  to	  the	  cell42,43	  ,	  features	  that	  play	  an	  important	  role,	  facilitating	  and	  regulating	  intracellular	  reactions	  and	  moreover	  providing	  a	  heterogeneous	  distribution	  of	  molecules.	  This	  is	  the	  reason	  for	  which	  we	  think	  that	  just	  a	  boundary	  with	  an	  aqueous	  phase	  is	  not	  representative	  of	  a	  cell,	  and	  we	  considered	  logic	  the	  incorporation	  of	  a	  synthetic	  cytoplasm	  in	  cell-­‐like	  compartment.	  	  	  	   When	  two	  or	  more	  incompatible	  polymers	  are	  mixed	  at	  appropriate	  concentrations	  in	  aqueous	  solution,	  phase	  separation	  occurs	  resulting	  in	  two	  aqueous	  phases	  or	  microcompartments44-­‐45.	  Immiscibility	  arises	  due	  to	  the	  high	  molecular	  weight	  of	  the	  polymers	  combined	  with	  interactions	  (van	  der	  Waals,	  hydrogen	  bonding,	  and	  ionic	  forces)	  between	  the	  polymer	  segments	  and	  can	  be	  influenced	  by	  temperature,	  inorganic	  salts,	  and	  pH	  .	  	  	  	  	   	  We	  encapsulated	  in	  emulsion	  aqueous	  two	  phase	  systems	  made	  of	  polymers	  such	  as	  dextran,	  polyethylen	  glycol	  (PEG)	  and	  aqueous	  three	  phase	  systems	  made	  of	  dextran,	  PEG	  and	  ficoll	  dispersed	  in	  water,	  developing	  multicompartment	  systems	  useful	  for	  protein	  localization.	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  Chapter	  2	  	  
Development	  of	  multi	  compartmentalized	  water-­‐in-­‐oil	  emulsion	  for	  the	  
topography	  of	  genetically	  encoded	  system.	  
	  2.1	  Introduction	  	   The	  synthesis	  of	  our	  minimal	  artificial	  cell	  requires	  a	  logical	  choice	  of	  proteins	  from	  the	  divisome	  and	  the	  development	  of	  compartments	  with	  physicochemical	  properties	  able	  to	  make	  division.	  Keating	  and	  colleagues,	  as	  mentioned	  before,	  developed	  GVs	  ATPS	  as	  models	  of	  non	  living	  cell-­‐like	  compartments.	  GVs	  ATPS	  are	  models	  of	  cell	  apolarity,	  have	  a	  budding	  morphology	  after	  osmotic	  deflation,	  and	  are	  able	  to	  divide	  asymmetrically.	  Although	  the	  presence	  of	  the	  ATPS	  inside	  the	  GVs	  is	  able	  to	  mimic	  the	  cytoplasm46,47	  ,	  there	  are	  no	  biological	  features	  in	  these	  multi-­‐compartmentalized	  systems.	  The	  bottleneck	  is	  represented	  by	  the	  encapsulation	  of	  ATPS	  inside	  GVs.	  	  ATPS	  can	  be	  captured	  by	  GVs	  only	  through	  a	  phase	  transition,	  a	  process	  not	  compatible	  with	  in	  vitro	  transcription/translation	  machinery	  and	  consequentially	  not	  compatible	  with	  building	  cellular	  mimics	  from	  the	  bottom-­‐up.	  Phase	  diagrams	  help	  to	  determine	  the	  conditions	  necessary	  and	  the	  polymer	  concentrations	  needed	  to	  achieve	  immiscibility	  at	  different	  temperatures.	  	  	   	  We	  demonstrated	  that	  w/o	  emulsion,	  due	  to	  their	  high	  stability	  and	  high	  efficiency	  of	  encapsulation	  of	  water	  phases,	  are	  good	  cell-­‐like	  compartments	  for	  the	  development	  of	  genetically	  encoded	  systems.	  W/o	  emulsions	  are	  able	  not	  only	  to	  encapsulate	  directly	  ATPS	  in	  two	  phases,	  but	  also	  ATPS	  containing	  all	  the	  components	  necessary	  for	  in	  vitro	  transcription/translation	  reaction.	  Furthermore,	  the	  process	  of	  encapsulation	  is	  independent	  of	  phase	  diagrams	  and	  temperature	  transitions,	  permitting	  the	  development	  of	  complex	  compartments	  made	  of	  three	  polymers,	  called	  Aqueous	  Three	  Phase	  System	  (A3PS).	  A3PS,	  composed	  of	  dextran	  10	  kDa,	  ficoll	  400	  kDa	  and	  PEG	  8	  kDa	  are	  new	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compartments	  and	  permit	  to	  have	  a	  more	  compartmentalized	  environment	  for	  the	  spatial	  localization	  of	  biological	  components.	   	  	  	  2.2	  Materials	  and	  Methods	  
	  2.2.1	  Chemical	  and	  Materials	  
	   Polymers	  PEG	  8,000	  Da,	  PEG	  5,000	  Da,	  dextran	  10,000	  Da,	  ficoll	  400,000	  Da	  and	  PEG	  5,000	  Da	  (o-­‐(2-­‐aminoethyl)-­‐o-­‐methylpolyethylene)	  were	  purchased	  from	  Sigma-­‐Aldrich.	  PEG	  20,000	  Da	  was	  purchased	  from	  Nektar.	  Mineral	  Oil	  (#M-­‐5904)	  ,	  Span	  80	  (Fluka)	  and	  Tween	  80	  (#P-­‐8074)	  for	  the	  emulsion	  composition	  were	  purchased	  from	  Sigma-­‐Aldrich.	  Sodium	  Dodecyl	  Sulphate	  (SDS)	  powder	  was	  purchased	  by	  Sigma-­‐Aldrich.	  Alexa	  647-­‐conjugated	  dextran	  10,000	  Da	  and	  Alexa	  488	  for	  PEG	  labeling	  were	  purchased	  from	  Molecular	  Probes,	  Life	  Technologies.	  Tethramethylrhodamine	  isothiocyanate	  conjugated	  ficoll	  40,000	  Da	  was	  purchased	  from	  Sigma-­‐Aldrich.	  Distilled	  water	  was	  purified	  to	  a	  resistivity	  of	  ≥	  18.2	  MΩ	  with	  a	  Barnstead	  NANOPure	  Diamond	  system.	  Silicone	  spacers	  were	  from	  Molecular	  Probes	  (Life	  Technologies)	  and	  were	  used	  to	  enclose	  ATPS/emulsions	  on	  microscope	  slides	  for	  imaging.	  	  
	  2.2.2	  ATPS	  and	  A3PS	  	  composition.	  	  	   Three	  different	  ATPS	  compositions	  were	  encapsulated	  in	  mineral	  oil	  emulsions:	  19.8%	  dextran	  10	  kDa	  and	  2.8%	  PEG	  8	  kDa,	  10	  %	  dextran	  10	  kDa	  and	  7%	  PEG	  8kDa	  and18.5	  %	  dextran	  10	  kDa	  and	  5.5%	  PEG	  8	  kDa.	  The	  polymers	  were	  dissolved	  in	  distilled	  water	  purified	  to	  a	  resistivity	  of	  ≥	  18.2	  MΩ	  and	  stirred	  on	  a	  magnetic	  stir	  plate	  until	  the	  solution	  became	  turbid.	  	   The	  A3PS	  composition	  inserted	  in	  emulsion	  was	  19.8%	  dextran	  10	  kDa,	  2.8%	  PEG	  8	  kDa,	  6%	  Ficoll	  400	  kDa.	  A3PS	  were	  produced	  by	  simply	  pipetting	  with	  a	  positive	  displacement	  pipettman1	  mL	  of	  Ficoll	  400	  kDa,	  30%	  w/w	  stock	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solution	  into	  a	  bulk	  ATPS	  of	  19.8%	  w/w	  dextran	  10kDa,	  2.8%	  w/w	  PEG	  8	  kDa	  .	  The	  final	  composition	  of	  A3PS	  is	  19.8%	  w/w	  dextran	  10kDa,	  6%	  Ficoll	  400	  kDa	  and	  2.8%	  PEG	  8	  kDa.	  	  	  	  2.2.3	  	  Treatment	  of	  the	  w/o	  emulsion	  with	  SDS.	  
	  A	  stock	  solution	  of	  2	  M	  SDS	  was	  prepared	  in	  70%	  methanol.	  To	  50	  µL	  of	  ATPS	  (19.8%	  dextran	  10	  kDa,	  2.8%	  PEG	  8	  kDa)	  in	  an	  Eppendorf	  tube,	  the	  SDS	  was	  added	  to	  a	  final	  concentration	  of	  0.1	  µM,	  1	  µM,	  10	  µM,	  25	  mM,	  100	  mM.	  	  	  2.2.4	  Encapsulation	  of	  Aqueous	  Two	  phase	  System	  in	  w/o	  emulsion.	  	   The	  oil	  phase	  was	  freshly	  prepared	  by	  mixing	  4.5%	  (vol/vol)	  Span	  80	  and	  0.5	  %	  (vol/vol)	  Tween	  80	  in	  0.95	  mL	  of	  mineral	  Oil.	  This	  mixture	  was	  vortex	  until	  the	  Span	  80	  was	  completely	  dissolved	  in	  the	  mineral	  oil.	  0.05	  mL	  of	  bulk	  ATPS	  or	  bulk	  A3PS	  were	  added	  to	  the	  oil	  phase	  and	  vigorously	  vortex	  until	  the	  dispersion	  became	  cloudy.	  	  
	  2.2.5	  Encapsulation	  of	  in	  vitro	  transcription/translation	  system	  in	  ATPS/emulsion	  and	  expression	  of	  m	  YPET	  	   The	  mixture	  for	  protein	  production	  was	  prepared	  in	  a	  test	  tube	  by	  adding	  250	  ng	  of	  plasmid	  DNA	  encoding	  mYPet	  to	  20	  μL	  of	  the	  in	  vitro	  transcription/translation	  system.	  For	  the	  in	  vitro	  transcription/translation	  system	  we	  used	  the	  PURESYSTEM	  (NEB,	  New	  England	  Biolabs).	  The	  reaction	  was	  performed	  on	  ice	  in	  order	  to	  prevent	  unnecessary	  reaction	  and	  then	  the	  reaction	  was	  encapsulated	  in	  ATPS,	  gently	  mixing	  in	  an	  Eppendorf	  tube	  25	  µL	  of	  ATPS	  (19.8	  %	  dextran	  10	  kDa,	  2.8	  %	  PEG	  8	  kDa)	  and	  25	  µL	  of	  reaction.	  The	  reaction	  was	  encapsulated	  inside	  the	  ATPS	  was	  further	  encapsulated	  into	  to	  the	  oil	  phase,	  as	  described	  previously48.	  The	  expression	  of	  mYPET	  was	  obtained	  by	  incubating	  the	  emulsion	  at	  37	  °C	  for	  at	  least	  2	  hours.	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2.2.6	  Preparation	  of	  A2PS	  and	  A3PS/emulsion	  samples	  and	  PURE	  SYSTEM	  ATPS/Emulsion	  samples	  for	  confocal	  microscopy.	  	   The	  dextran	  phase	  in	  A2PS/emulsion	  samples	  was	  labeled	  with	  Alexa	  647	  conjugated	  dextran	  10	  kDa	  or	  with	  Alexa	  647	  conjugated	  dextran	  40kDa	  with	  a	  final	  concentration	  of	  4	  mg/mL.	  The	  PEG	  phase	  in	  A2PS/emulsion	  samples	  was	  labeled	  with	  Alexa	  488	  conjugated	  PEG	  20	  kDa	  with	  a	  final	  concentration	  of	  7.2	  mg/mL.	  The	  dextran	  phase	  in	  A3PS/emulsion	  samples	  was	  labeled	  with	  Alexa	  647	  conjugates	  dextran	  10	  kDa	  or	  with	  Alexa	  647	  conjugated	  dextran	  40	  kDa	  with	  a	  final	  concentration	  of	  0.8	  mg/mL.	  	  The	  PEG	  phase	  was	  labeled	  with	  Alexa	  488	  conjugated	  PEG	  20	  kDa	  or	  PEG	  5	  KDa	  with	  a	  final	  concentration	  of	  3.6	  mg/mL.	  Finally	  the	  Ficoll	  phase,	  in	  A3PS	  emulsion,	  was	  labeled	  with	  tethramethylrhodamine	  isothiocyanate	  at	  a	  final	  concentration	  of	  12	  mg/mL.	  The	  expression	  of	  mYPet,	  that	  has	  an	  excitation	  wavelength	  at	  517nm	  and	  an	  emission	  at	  530	  nm,	  inside	  ATPS/emulsion	  was	  evaluated	  by	  confocal	  microscopy	  exploiting	  the	  fluorescent	  properties	  of	  the	  protein.	  	   A2PS,	  A3PS	  and	  PURE	  SYSTEM	  /ATPS	  emulsion	  samples	  were	  observed	  in	  sample	  chambers,	  constructed	  by	  placing	  a	  20	  x	  5-­‐mm	  silicon	  spacer	  (Molecular	  Probes)	  onto	  a	  microscope	  slide.	  	  	  2.2.7	  Instrumentation.	  	  	   Confocal	  images	  were	  obtained	  with	  a	  Leica	  TCS	  SP5	  laser	  scanning	  confocal	  inverted	  microscope	  using	  a	  63x	  oil	  objective	  equipped	  with	  galvanometric	  stage	  and	  a	  63.3x	  /1.4	  NA	  HCX	  PL	  APO	  oil	  -­‐	  immersion	  objective.	  Z	  step	  size	  was	  0.3	  µm	  or	  where	  mentioned	  0.1	  µm.	  Ar,	  He	  and	  Ne	  laser	  lines	  were	  used	  for	  mYPet	  (λ	  =	  517	  nm),	  Alexa-­‐647	  (λ	  =	  633	  nm),	  Alexa	  488	  (λ	  =	  488	  nm)	  excitation,	  	  Rhodamine	  thio-­‐isocyanate	  (λ	  =	  543	  nm).	  Fluorescence	  emission	  was	  collected	  	  in	  the	  ranges	  527–600,	  670–750	  (Alexa	  647),	  498-­‐550	  nm,	  553-­‐600	  for	  mYPet,	  Alexa	  647,	  and	  Alexa	  488,	  Rhodamine	  Thioisocianate,	  respectively.	  For	  the	  two-­‐	  and	  three-­‐color	  analysis,	  a	  sequential	  image	  acquisition	  was	  used	  to	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reduce	  crosstalk	  between	  different	  signals	  below	  5%.	  Multichannel	  images	  were	  analyzed	  in	  ImageJ	  (NIH.gov).	  	  	  2.3	  Results	  and	  Discussion	  	  2.3.1	  Encapsulation	  of	  ATPS	  in	  w/o	  emulsions.	  
	   In	  general	  the	  construction	  of	  a	  phase	  diagram	  is	  of	  crucial	  importance	  for	  the	  encapsulation	  of	  ATPS	  in	  GVs	  and	  for	  the	  understanding	  of	  polymer	  compositions	  to	  use.	  In	  order	  to	  define	  the	  conditions	  for	  the	  encapsulation	  of	  ATPS	  inside	  of	  water-­‐in-­‐oil	  emulsions	  we	  tried	  to	  build	  phase	  diagrams	  at	  different	  temperatures	  using	  the	  method	  of	  cloud	  point	  titration.	  In	  this	  method,	  one	  aqueous	  polymer	  solution	  (PEG	  8	  kDa)	  is	  added	  drop	  wise	  to	  the	  other	  aqueous	  polymer	  solution	  (dextran	  10	  kDa)	  until	  the	  solution	  turns	  opaque,	  an	  indication	  that	  the	  polymer	  solution	  is	  entering	  in	  the	  two-­‐phase	  region.	  Water	  is	  then	  added	  to	  the	  point	  at	  which	  the	  solution	  turns	  clear.	  The	  weights	  of	  the	  polymer	  solutions	  are	  recorded	  at	  each	  step,	  and	  the	  procedure	  is	  repeated.	  A	  graph	  of	  the	  polymer	  weight	  percent	  compositions	  is	  constructed,	  and	  the	  compositions	  at	  which	  the	  solution	  is	  one	  or	  two-­‐phases	  is	  determined	  by	  a	  binodial	  curve.	  At	  polymer	  weight	  percentage	  below	  the	  binodial,	  the	  solution	  exists	  as	  a	  single	  phase	  while	  above	  the	  line,	  phase	  separation	  will	  occur.	  In	  Fig.	  2.1	  is	  reported	  a	  phase	  diagram	  at	  4	  °C	  for	  our	  system	  made	  of	  PEG	  8	  kDa	  and	  dextran	  10	  kDa.	  The	  phase	  diagram	  reported	  does	  not	  show	  the	  typical	  profile	  of	  a	  binodial	  curve,	  but	  was	  useful	  to	  verify	  some	  points	  above	  the	  curve,	  if	  arise	  in	  two	  phase,	  and	  a	  couple	  below	  the	  curve,	  if	  arise	  in	  one	  phase.	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  `	  2.2:	  	  A	  composition	  19.8%	  dextran	  10	  kDa	  and	  2.8	  %	  PEG	  8	  kDa	  	  is	  encapsulated	  in	  w/	  o	  emulsion.	  The	  dextran	  occupy	  the	  major	  part	  of	  the	  volume	  of	  the	  droplets	  .The	  droplets	  show	  a	  budding	  morphology.	  The	  rhodamine	  is	  spread	  in	  the	  oil.	  W/o	  emulsions	  ATPS	  are	  	  false	  colored,	  in	  green	  for	  PEG	  8	  kDa	  labeled	  with	  PEG	  20kDa-­‐Alexa	  488(A),	  in	  blu	  for	  Dextran	  10	  kDa	  labeled	  with	   Dextran	   20kDa-­‐Alexa	   647(B),	   in	   red	   for	   the	  mineral	   oil	   labeled	   with	   Rhodamine-­‐HCl(D).	  Panel	  C	  is	  a	  merge	  of	  all	  the	  three	  channels.	  	  	  	  	   We	  observed	  that	  the	  composition	  of	  the	  emulsion	  used,	  4.5%	  (vol/vol)	  Span	  80	  and	  0.5	  %	  (vol/vol)	  Tween	  80	  in	  0.95	  mL	  of	  mineral	  oil	  provided	  a	  good	  efficiency	  of	  encapsulation.	  In	  fact,	  with	  a	  modification	  of	  the	  percentage	  in	  volume	  of	  the	  surfactants	  to	  3%	  (vol/vol)	  Tween	  80	  and	  2%	  (vol/vol)	  Span	  80,	  the	  emulsion	  lost	  the	  ability	  of	  retaining	  the	  two	  phases	  (Fig	  2.3).	  We	  observed	  many	  droplets	  containing	  just	  the	  dextran	  phase	  or	  the	  PEG	  phase	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Fig	  2.3:	  w/o	  emulsion	  ATPS	  with	  a	  modified	  surfactant	  composition.	  The	  efficiency	  of	  encapsulation	  of	  the	  emulsion	  of	  the	  two	  phases	  is	  reduced	  The	  droplets	  are	  not	  compartmentalized	  anymore,	  but	  retain	  in	  their	  inner	  volume,	  the	  PEG	  or	  the	  dextran.	  False	  color	  in	  red	  for	  Dextran	  labeled	  with	  Dextran	  20kDa-­‐Alexa	  647,	  and	  green	  for	  PEG	  labeled	  with	  PEG	  20kDa-­‐Alexa	  488.	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The	  droplets	  had	  an	  interesting	  budding	  morphology	  (Fig.2.4)	  without	  the	  presence	  of	  any	  osmotic	  deflation	  and	  we	  observed	  that	  the	  polymers	  composition	  influenced	  the	  morphology	  of	  the	  droplets.	  	  	  In	  contrast,	  another	  composition	  encapsulated	  (5.5%	  w/w	  PEG	  8kDa	  and	  18.5%	  w/w	  Dextran	  10	  kDa),	  existing	  in	  two	  phases	  according	  to	  the	  phase	  diagram,	  showed	  a	  non	  budding	  morphology	  (Fig.	  2-­‐4,	  B),	  but	  clearly	  the	  droplets	  had	  two	  compartments.	  In	  both	  the	  cases	  the	  PEG	  occupy	  less	  volume	  compared	  to	  the	  dextran.	  	  	  
	  






	  	   22	  
The	  same	  polymer	  composition,	  dextran	  10	  kDa,	  10%	  w/w	  and	  PEG	  8	  KDa	  7%	  w/w,	  previously	  encapsulated	  in	  GVs	  is	  easily	  encapsulated	  in	  w/o	  emulsion	  directly	  in	  two	  phase	  without	  any	  phase	  transition	  and	  similarly	  assumed	  a	  budding	  morphology	  (Fig	  2-­‐5).	  The	  advantage	  of	  our	  system	  is	  that	  we	  were	  able	  to	  encapsulate	  the	  polymers	  directly	  in	  two	  phase	  without	  undergo	  to	  phase	  transition,	  that	  in	  the	  case	  of	  the	  ATPS	  composition	  in	  GVs,	  was	  occurring	  at	  43°C.	  	  	  
	  
Fig	  2.5:	  ATPS	  encapsulated	  in	  water-­‐oil	  emulsions.	  The	  ATPS	  composition	  encapsulated	  is	  dextran	  10	  kDa,	  10%	  w/w	  and	  PEG	  8	  KDa	  7%	  w/w.	  This	  composition	  was	  previously	  encapsulated	  in	  giant	  vesicles.	  W/o/ATPS	  show	  a	  budding	  morphology.	  Scale	  bar	  is	  25	  µm.	  On	  the	  left	  DIC	  images	  are	  shown.	  Fluorescence	  images	  have	  been	  false	  colored:	  PEG	  is	  labeled	  with	  PEG	  20kDa-­‐Alexa	  488	  and	  is	  green.	  Dextran	  is	  labeled	  with	  Dextran	  20kDa-­‐Alexa	  647	  and	  is	  red.	  	  	  	  2.	  3.2	  Treatment	  of	  w/o	  emulsions	  with	  SDS	  micelles.	  	  The	  budding	  morphology	  showed	  by	  certain	  ATPS	  composition	  lead	  us	  to	  test	  the	  efficiency	  of	  the	  droplets	  to	  retain	  two	  phases.	  We	  treated	  a	  w/o	  ATPS	  (19.8%	  dextran	  10	  kDa,	  2.8%	  PEG	  8	  kDa)	  with	  SDS	  micelles	  in	  order	  to	  see	  changing	  of	  morphology.	  We	  noticed	  that	  in	  absence	  of	  SDS	  or	  in	  the	  presence	  of	  a	  low	  amount	  of	  SDS,	  such	  as	  0.1	  mM	  and	  1	  mM,	  the	  w/o	  emulsions	  keep	  the	  compartmentalization	  in	  two	  phase	  and	  the	  budding	  morphology	  (Fig.2.6-­‐Fig	  2.7).	  Increasing	  the	  concentration	  of	  the	  SDS	  in	  the	  sample,	  we	  observed	  droplets	  containing	  just	  one	  of	  the	  two	  phases	  in	  their	  inner	  volume,	  suggesting	  that	  the	  droplets	  were	  dividing.	  In	  some	  samples	  treated	  with	  25	  mM	  SDS,	  we	  noticed	  droplets	  directed	  to	  a	  process	  of	  fission	  (Fig.2.8)	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Fig.	  2.6:	  SDS	  causes	  changing	  in	  the	  morphology	  of	  the	  w/o	  ATPS	  droplets.	  In	  absence	  of	  the	  SDS	  (panel	  A)	  the	  droplets	  have	  the	  ability	  of	  retain	  two	  phases	  in	  their	  inner	  volume.	  The	  major	  amount	  of	  droplets	  of	  dextran,	  false	  colored	  in	  red	  and	  labeled	  with	  dextran	  20	  kDa-­‐Alexa	  647,	  is	  due	  to	  the	  fact	  that	  the	  ATPS	  composition	  used	  forecasts	  an	  higher	  amount	  of	  dextran	  versus	  PEG	  (	  19.8	  %	  dextran	  10	  kDa	  and	  2.8	  %	  PEG	  8	  kDa).	  In	  presence	  of	  0.1	  µM	  (panel	  B)	  and	  1	  µM	  (panel	  C)	  the	  droplets	  are	  still	  retaining	  their	  internal	  compartmentalization.	  The	  images	  on	  the	  top	  are	  acquired	  in	  bright-­‐field,	  the	  images	  on	  the	  bottom	  are	  merge	  of	  red	  (dextran)	  and	  green	  (PEG),	  labeled	  as	  mentioned	  other	  times.	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Fig.2.7:	  SDS	  causes	  changing	  in	  the	  morphology	  of	  the	  w/o	  ATPS	  droplets.	  The	  behavior	  observed	  suggests	  the	  possibility	  that	  the	  droplets,	  in	  presence	  of	  micelles	  of	  SDS	  can	  divide.	  	  Increasing	  concentration	  of	  SDS	  progressively,	  it	  is	  possible	  to	  see	  that	  the	  droplets	  loose	  their	  ability	  to	  retain	  the	  two	  phases.	  Bright	  field	  and	  merged	  images	  (dextran	  false	  colored	  in	  red,	  PEG	  false	  colored	  in	  green).	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  Fig	  2.8:	  	  Fission	  of	  w/o	  emulsion	  ATPS	  in	  presence	  of	  25	  mM	  of	  SDS.	  Together	  with	  the	  loosing	  of	  ability	  of	  retaining	  two	  phases,	  we	  noticed	  that	  some	  droplets	  were	  engaged	  in	  a	  process	  of	  fission.	  This	  fact	  strongly	  motivated	  us	  to	  consider	  that	  division	  was	  occurring.	  	  	  2.3.3	  Expression	  of	  fluorescent	  proteins	  in	  w/o	  	  ATPS.	  	   Multi	  compartmentalized	  water-­‐in-­‐oil	  emulsion	  with	  their	  features	  of	  easy	  preparation,	  have	  the	  big	  advantage	  of	  direct	  encapsulation	  of	  ATPS,	  showing	  ideal	  characteristics	  to	  guest	  in	  vitro	  T/T.	  	  Ideally	  an	  in	  vitro	  T/T,	  housed	  in	  compartments	  like	  these,	  should	  be	  able	  to	  produce	  proteins	  and	  the	  proteins	  once	  produced	  could	  distribute	  in	  one	  of	  two	  compartments.	  We	  successfully	  expressed	  mYPET	  in	  w/o	  emulsions,	  using	  the	  PURESYSTEM.	  The	  protein	  once	  produced	  preferred	  mostly	  the	  dextran	  phase	  (Fig	  2.9).	  mYPet	  has	  an	  excitation	  wavelength	  at	  517	  nm	  and	  an	  emission	  at	  530	  nm,	  and	  its	  expression	  was	  evaluated	  by	  confocal	  microscopy.	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  Fig	  2.9:	  Expression	  by	  PURE	  SYSTEM	  of	  A206KYPet	  in	  w/o/ATPS.	  	  A	  PURE	  SYSTEM	  	  	  	  	  	  	  	  	  	  	  reaction	  expressing	  mYPet,	  was	  mixed	  with	  25	  µL	  of	  ATPS,	  then	  encapsulated	  in	  w/o	  emulsion	  and	  incubated	  for	  2	  h	  at	  37°C.The	  protein	  prefers	  the	  Dextran	  phase.	  On	  the	  left	  BF	  image	  on	  the	  right	  fluorescence	  image	  false	  	  	  colored	  in	  gold.	  Scale	  bar	  is	  10	  µm.	  The	  expression	  of	  mYPet	  (Ex=517nm,	  Em=530nm)	  inside	  ATPS/emulsion	  was	  evaluated	  by	  confocal	  microscopy	  exploiting	  the	  fluorescent	  properties	  of	  the	  protein.	  	  	   We	  aim	  to	  build	  genetically	  encoded	  systems	  in	  multi	  compartmentalized	  w/o	  emulsions	  for	  spatially	  localized	  biological	  components.	  In	  particular	  we	  want	  	  to	  build	  a	  genetically	  encoded	  system	  expressing	  FtsZ	  and	  FtsA	  	  and	  localize	  them	  in	  these	  compartments.	  In	  Fig.2.10	  we	  show	  expression	  of	  YFP-­‐FtsZ-­‐FtsA	  inside	  w/o	  ATPS	  emulsions.	  We	  can	  notice	  expression	  of	  	  YFP-­‐FtsZ-­‐FtsA	  	  with	  a	  distribution	  in	  the	  dextran	  phase	  with	  some	  polymers	  distributing	  at	  the	  interface.	  	  	  	  	  	  	  	  	   	  






	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Fig	  2.10:YFP-­‐FtsZ-­‐FtsA	  is	  expressed	  by	  PURESYSTEM	  in	  w/o	  emulsions	  ATPS	  after	  2	  h.	  Is	  	  	  possible	  to	  notice	  some	  aggregation	  of	  FtsZ	  proto	  filaments	  in	  the	  dextran	  phase.	  	  
	  Top,	  from	  the	  right,	  DIC	  image	  of	  a	  w/o	  emulsion	  ATPS	  expressing	  a	  YFP-­‐FtsZ-­‐FtsA	  by	  PURESYSTEM.	  False	  coloration	  green	  is	  for	  the	  expression	  of	  YFP-­‐FtsZ-­‐FtsA	  (YFP=YPet,	  Ex=517	  nm,	  Em=530	  nm),	  false	  coloration	  is	  blu	  for	  Dextran	  10	  kDa	  labeled	  with	  Dextran	  20	  kDa	  -­‐Alexa	  647.	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  2.3.4	  Encapsulation	  of	  A3PS	  in	  w/o	  emulsions.	  	  The	  exciting	  possibility	  of	  spatially	  localizing	  proteins	  once	  produced,	  lead	  us	  to	  develop	  water-­‐in-­‐oil	  emulsions	  containing	  Aqueous	  Three	  Phase	  Systems	  (A3PS).	  Aqueous	  Three	  Phase	  Systems	  are	  made	  of	  three	  polymers:	  dextran	  10	  kDa,	  PEG	  8	  kDa	  and	  Ficoll	  400	  kDa.	  The	  third	  phase	  is	  generated	  simply	  by	  adding	  a	  solution	  of	  30%	  w/w	  of	  Ficoll	  400	  kDa	  to	  an	  ATPS	  with	  a	  composition	  of	  19.8%	  w/w	  Dextran	  and	  2.8%	  w/w	  PEG	  8	  kDa.	  Water-­‐in-­‐oil	  emulsions,	  also	  in	  this	  case,	  showed	  to	  be	  ideal	  for	  the	  direct	  encapsulation	  of	  A3PS	  in	  three	  phases	  (Figure	  2.11).	  The	  third	  phase	  is	  represented	  by	  the	  Ficoll	  400	  and	  is	  the	  dark	  phase	  between	  the	  dextran	  phase	  (Dextran	  40	  kDa-­‐Alexa647)	  and	  the	  PEG	  phase	  (PEG	  20	  kDa-­‐	  Alexa	  488),	  (Fig	  2.11).	  	  	  
	  
Fig	  2.11:	  A3PS	  are	  directly	  encapsulated	  inside	  water-­‐oil	  emulsion.	  A3PS	  are	  produced	  by	  adding	  ficoll	  400	  kDa,	  to	  a	  bulk	  ATPS	  made	  of	  19.8%	  dextran	  10	  kDa	  and	  2.8%	  PEG	  8	  kDa.	  On	  the	  left	  DIC	  image.	  Fluorescent	  images	  are	  false	  colored	  in	  red	  for	  Dextran	  40kDa-­‐Alexa	  647,	  in	  green	  PEG	  20kDa-­‐Alexa	  488	  .	  In	  the	  middle	  of	  this	  two	  phase	  there	  is	  the	  ficoll	  400	  kDa,	  labeled	  with	  	  	  ficoll	  40	  kDa	  tethramethylrhodamine	  isothiocyanate	  .	  Scale	  bar	  is10	  µm.	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In	  order	  to	  confirm	  the	  presence	  of	  the	  third	  phase	  between	  the	  Dextran	  and	  the	  PEG,	  we	  labeled	  the	  Ficoll	  400	  kDa	  using	  ficoll	  40	  kDa	  tethramethylrhodamine	  isothiocyanate.	  The	  emulsion	  is	  able	  to	  retain	  effectively	  in	  the	  aqueous	  compartment	  three	  polymers	  that	  separate	  according	  to	  their	  physicochemical	  properties	  and	  their	  molecular	  weight	  (Fig.2.10).	  	  	  
	  
Fig	  2.10:	  Is	  possible	  to	  label	  the	  third	  phase	  constituted	  by	  the	  ficoll	  400	  kDa	  in	  w/o	  A3PS.	  The	  A3PS	  composition	  is	  of	  19.8%	  dextran	  10	  kDa,	  2.8%	  PEG	  8	  kDa,	  6	  %	  ficoll	  400	  kDa.	  	  DIC	  images(panel	  D).	  Fluorescent	  images	  are	  false	  colored,	  in	  red	  for	  the	  Ficoll	  400	  kDa	  labeled	  with	  Ficoll	  40	  kDa	  tethramethylrhodamine	  isothiocyanate	  (panel	  A),	  in	  green	  for	  PEG	  labeled	  with	  PEG	  20	  kDa-­‐	  Alexa	  488	  (panel	  B),	  in	  blu	  for	  Dextran	  labeled	  with	  Dextran	  40kDa-­‐Alexa	  647.	  Scale	  bar	  is	  25	  µm.	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  Chapter	  3	  	  	  	  
	  
Reconstitution	  of	  a	  synthetic	  minimal	  divisome	  in	  w/o	  emulsions	  and	  in	  
phospholipids	  vesicles	  	  
	  3.1	  Introduction	  	   Cell	  body	  division	  is	  a	  feature	  of	  life	  still	  difficult	  to	  be	  reproduced	  in	  a	  laboratory.	  There	  are	  advancements,	  as	  discussed	  before,	  that	  demonstrate	  the	  possibility	  to	  reconstitute	  the	  main	  features	  of	  cell	  body	  division	  in	  cell-­‐like	  compartments	  and	  the	  difficulty	  in	  mediating	  compartments	  division.	  Herein	  we	  describe	  our	  efforts	  to	  reconstitute	  a	  genetically	  encoded	  system	  of	  minimal	  division	  machinery	  both	  in	  phospholipids	  vesicles	  and	  in	  w/o	  emulsions.	  We	  developed	  a	  genetically	  encoded	  system	  made	  of	  FtsZ	  and	  FtsA.	  FtsZ	  and	  FtsA	  ,	  in	  w/o	  emulsions	  and	  in	  phospholipids	  vesicles,	  assemble	  together	  and	  form	  ring-­‐like	  structures.	  	   The	  assembly	  of	  our	  genetically	  encoded	  system	  required	  the	  engineering	  of	  some	  fluorescent	  constructs	  to	  monitor	  the	  expression	  of	  FtsZ	  and	  FtsA	  in	  the	  compartments	  and	  the	  choice	  of	  a	  T/T	  system	  for	  their	  optimal	  expression.	  Ericksson	  and	  colleagues,	  as	  discussed	  in	  the	  first	  chapter,	  demonstrated	  that	  a	  FtsZ-­‐YFP-­‐MinD,	  purified	  and	  encapsulated	  in	  multilamellar	  tubular	  liposomes21	  	  ,	  is	  able	  to	  reproduce	  the	  typical	  phenomena	  of	  cell	  division.	  FtsZ,	  in	  this	  construct,	  comprise	  amino	  acids	  from	  1-­‐366	  of	  E.	  coli	  sequence	  and	  at	  the	  C-­‐terminus	  has	  a	  yellow	  fluorescent	  protein	  (YFP-­‐Venus)	  followed	  by	  an	  amphiphatic	  helix	  made	  of	  15	  aminoacids	  (FIEEEKKGFLKRLFGG).	  It	  is	  important	  to	  notice	  that	  the	  amphiphatic	  helix	  is	  the	  membrane	  targeting	  sequence	  (MTS)	  of	  MinD	  and	  is	  similar	  to	  the	  amphiphatic	  helix	  of	  FtsA	  sequence.49	  	  Although	  FtsZ-­‐YFP-­‐MinD	  forms	  polymers	  in	  liposomes	  that	  generate	  membrane	  indentations,	  the	  Z-­‐ring	  does	  not	  divide	  the	  liposome	  into	  daughter	  compartments.	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FtsZ-­‐YFP-­‐MinD	  is	  an	  engineered	  version	  of	  FtsZ	  with	  remarkable	  activity	  that,	  nevertheless,	  is	  incapable	  of	  mediating	  divison.	  We	  envisioned	  exploiting	  similar	  and	  more	  natural	  divisome	  machinery	  in	  cell-­‐like	  compartments.	  However,	  our	  systems	  would	  be	  genetically	  encoded	  rather	  than	  relying	  on	  purified	  proteins.	  Towards	  this	  end,	  we	  engineered	  a	  pool	  of	  genetic	  constructs	  that	  were	  tested	  in	  vitro	  and	  then	  were	  combined	  in	  compartments	  in	  order	  to	  have	  a	  system	  potentially	  able	  to	  divide.	  Our	  pool	  of	  genetic	  constructs	  for	  FtsZ	  is	  represented	  by	  FtsZ-­‐YFP-­‐MinD	  and	  YFP-­‐FtsZ,	  for	  FtsA	  by	  Cyan	  fluorescent	  protein	  FtsA	  and	  superfolder-­‐GFP-­‐FtsA.	  Unfortunately,	  we	  were	  not	  able	  to	  produce	  in	  vitro	  a	  fluorescent	  version	  of	  FtsA	  and	  this	  lead	  us	  to	  design	  a	  system	  with	  just	  FtsZ	  labeled	  with	  a	  YFP.	  FtsZ	  and	  FtsA,	  although	  successfully	  produced	  in	  compartments,	  are	  not	  able	  to	  generate	  division	  and	  constriction	  of	  the	  compartments	  but	  are	  able	  to	  assemble	  in	  ring-­‐like	  structures.	  	  	  	  3.2	  Results	  and	  Discussion	  
	  3.2.1Engineering	  of	  fluorescent	  genetic	  constructs	  for	  the	  synthesis	  of	  a	  minimal	  divisome	  made	  of	  FtsZ	  and	  FtsA.	  
	   The	  detection	  of	  our	  genetically	  encoded	  system	  in	  vitro	  or	  in	  compartments	  needs	  the	  engineering	  of	  fluorescent	  genetic	  constructs.	  The	  engineering	  of	  fluorescents	  constructs	  permit	  evaluation	  by	  fluorescence	  spectroscopy	  and	  fluorescence	  microscopy	  of	  the	  synthesis	  of	  our	  minimal	  division	  machinery	  system	  in	  vitro	  and	  in	  compartments.	  In	  order	  to	  reach	  this	  goal,	  we	  engineered	  fluorescent	  genetic	  constructs	  for	  FtsZ	  and	  FtsA.	  	  	   FtsZ-­‐YFP-­‐MinD	  is	  our	  model	  construct	  for	  FtsZ.	  The	  sequence	  of	  FtsZ-­‐YFP-­‐MinD	  was	  synthesized	  in	  a	  pUC57	  vector	  by	  Genscript	  and	  then	  was	  subcloned	  in	  a	  pET21b	  vector.	  The	  design	  of	  the	  construct	  made	  by	  Ericksson,	  comprised	  1-­‐366	  amino	  acids	  of	  the	  FtsZ	  sequence	  from	  E.	  coli.	  In	  contrast,	  our	  version	  of	  FtsZ-­‐YFP-­‐MinD	  comprised	  1-­‐368	  amino	  acids	  of	  the	  sequence	  of	  FtsZ	  from	  E.	  coli,	  optimized	  by	  Genscript,	  followed	  by	  a	  YFP-­‐Venus	  and	  a	  C-­‐terminal	  helix	  from	  E.	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coli	  MinD.	  FtsZ-­‐YFP-­‐MinD	  at	  the	  N-­‐terminus	  has	  a	  tag	  of	  6	  Histidines	  (6HisX),	  useful	  for	  the	  later	  purification	  of	  the	  protein.	  Competent	  E.	  coli	  cells	  were	  transformed	  with	  the	  construct	  synthesized	  in	  a	  pUC57	  vector,	  encoding	  6HisX-­‐FtsZ-­‐YFP-­‐MinD.	  The	  plasmid	  DNA	  was	  extracted	  and	  purified	  and	  then	  amplified	  by	  polymerase	  chain	  reaction	  (PCR).	  Two	  different	  polymerases	  were	  tested,	  HotStart	  Taq	  DNA	  polymerase	  (NEB)	  and	  Taq	  DNA	  polymerase	  (RBC).	  The	  main	  difference	  between	  these	  two	  DNA	  polymerases	  is	  represented	  by	  the	  fact	  that	  the	  HotStart	  Taq	  DNA	  polymerase	  does	  not	  have	  activity	  at	  room	  temperature.	  HotStart	  Taq	  DNA	  polymerase	  is	  a	  mixture	  of	  Taq	  DNA	  polymerase	  and	  an	  aptamer-­‐based	  inhibitor.	  The	  inhibitor	  binds	  reversibly	  to	  the	  enzyme,	  inhibiting	  polymerase	  activity	  at	  temperatures	  below	  45°C,	  but	  releases	  the	  enzyme	  during	  normal	  cycling	  conditions,	  allowing	  reactions	  to	  be	  set	  up	  at	  room	  temperature.	  The	  presence	  of	  the	  inhibitor	  helps	  the	  specificity	  of	  the	  reaction	  of	  DNA	  amplification.	  However,	  both	  the	  two	  polymerases	  were	  able	  to	  amplify	  the	  gene	  encoding	  for	  FtsZ-­‐YFP-­‐MinD	  (Fig.3.1).	  The	  insert	  amplified	  by	  Taq	  polymerase	  was	  digested	  with	  NdeI	  and	  XhoI	  and	  ligated	  into	  a	  pET21b	  vector.	  	   	  
Fig.3.1:	  1%	  agarose	  gel	  electrophoresis	  in	  Tris-­‐Acetate-­‐EDTA	  (TAE)	  buffer	  1X.	  ftsZ-­‐yfp-­‐minD	  (pUC57)	  is	  properly	  amplified	  by	  Hot	  Start	  DNA	  polymerase	  (NEB)	  and	  Taq	  DNA	  Polymerase	  (RBC).	  The	  length	  of	  the	  gene	  is	  1962bp.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (NEB).	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FtsZ-­‐YFP-­‐MinD	  served	  as	  model	  for	  the	  later	  engineering	  of	  our	  own	  construct	  YFP-­‐FtsZ.	  This	  construct	  is	  designed	  in	  order	  to	  have	  the	  YFP	  (YPet)	  at	  the	  N-­‐terminus	  of	  FtsZ	  and	  the	  C-­‐terminus	  free	  for	  the	  interaction	  with	  FtsA.	  YFP-­‐FtsZ	  was	  synthesized	  by	  Genscript	  in	  a	  pUC57	  vector	  and	  comprised	  the	  whole	  sequence	  of	  FtsZ	  from	  E.	  coli.	  YFP-­‐FtsZ	  was	  amplified	  by	  Hot	  Start	  Taq	  DNA	  polymerase	  (NEB)	  and	  Taq	  DNA	  polymerase	  (RBC)	  (Fig.3.2)	  and	  then	  isolated	  from	  pUC57	  by	  BamHI	  and	  NdeI	  digestion	  followed	  by	  ligation	  into	  pET21b.	  We	  were	  able	  to	  subclone	  easily	  two	  fluorescent	  versions	  for	  FtsZ,	  ready	  to	  be	  used	  in	  our	  genetically	  encoded	  system.	  	  	   	  
Fig.3.2:	  1%	  agarose	  gel	  electrophoresis	  in	  Tris-­‐Acetate-­‐EDTA	  (TAE)	  buffer	  1X.	  yfp-­‐ftsZ	  (pUC57)	  is	  properly	  amplified	  by	  Hot	  Start	  DNA	  
Taq	  polymerase	  (NEB)	  and	  Taq	  DNA	  polymerase	  (RBC).The	  length	  of	  the	  gene	  is	  2015	  bp.	  The	  ladder	  used	  is	  a	  1	  kb	  ladder	  (NEB).	  	  	   	  	   	  	  	   We	  attempted	  to	  make	  fluorescent	  constructs	  also	  for	  FtsA,	  and	  in	  turn	  designed	  FtsA	  with	  the	  N-­‐terminus	  fused	  with	  a	  fluorescent	  protein	  and	  the	  C-­‐terminus	  free	  for	  the	  interaction	  with	  the	  membrane.	  The	  fluorescent	  proteins	  were	  designed	  with	  a	  6	  HisX	  tag	  at	  the	  N	  terminus.	  The	  constructs	  that	  we	  made	  for	  FtsA	  were	  labeled	  with	  a	  Cyan	  fluorescent	  protein	  (CFP-­‐FtsA,	  CFP-­‐R286W	  FtsA)	  or	  with	  super	  folder	  GFP	  (sfGFP-­‐FtsA).	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CFP-­‐FtsA	  was	  synthesized	  by	  Genscript	  in	  a	  pUC57	  vector	  and	  then	  subcloned	  in	  a	  pET21b	  vector.	  The	  CFP	  in	  this	  construct	  is	  a	  CyPet.	  CFP-­‐FtsA	  in	  pUC57	  was	  amplified	  by	  a	  HotStart	  Taq	  polymerase	  (NEB)	  and	  Taq	  polymerase	  (RBC)	  (Fig.3.3)	  and	  then	  digested	  by	  NdeI	  and	  BamHI	  and	  ligated	  	  into	  pET21b.	  For	  the	  construction	  of	  our	  genetically	  encoded	  system,	  on	  one	  hand	  we	  aimed	  to	  be	  minimal,	  respecting	  	  	  the	  logic	  of	  the	  cell	  division	  machinery	  system	  of	  E.	  coli	  	  	  and	  selecting	  the	  two	  key	  proteins	  that	  drive	  cell	  division,	  FtsZ	  and	  FtsA.	  On	  the	  other	  hand,	  we	  built	  a	  pool	  of	  genetic	  constructs	  to	  be	  combined	  in	  order	  to	  get	  compartments	  division.	  For	  this	  reason	  we	  enriched	  our	  pool	  of	  proteins	  with	  a	  mutated	  version	  of	  FtsA,	  R286W	  FtsA.	  R286W	  FtsA	  in	  vivo	  can	  substitute	  FtsA	  and	  divide	  E.	  coli	  cells,	  replacing	  the	  need	  of	  ZipA	  for	  cell	  division,	  and	  furthermore	  acts	  on	  FtsZ	  filaments	  .50	  This	  mutated	  version	  synthesized	  by	  Genscript	  in	  a	  pUC57	  vector,	  was	  amplified	  by	  PCR	  (Fig.	  3.4)	  and	  sub	  cloned	  exactly	  in	  the	  same	  way	  of	  CFP-­‐FtsA.	  	  	   	  
Fig.3.3:	  1%	  agarose	  gel	  electrophoresis	  in	  Tris-­‐Acetate-­‐EDTA	  (TAE)	  1X.	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Fig.3.4:	  1%	  agarose	  gel	  electrophoresis	  in	  Tris-­‐Acetate-­‐EDTA	  (TAE)	  1X.cfp-­‐R286W	  ftsA	  (pUC57)	  is	  properly	  amplified	  by	  Hot	  Start	  DNA	  Taq	  Polymerase	  (NEB)	  and	  Taq	  DNA	  Polymerase	  (RBC).	  The	  length	  of	  the	  gene	  is	  2070	  bp.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (NEB).	   	  	  	  	   	  	  	  
	  	   The	   expression	   of	   CFP-­‐FtsA	   and	   CFP-­‐R286W-­‐FtsA,	   as	   will	   be	   discussed	  later,	  was	  challenging	  both	  in	  vivo	  and	  in	  vitro.	  For	  this	  reason,	  we	  engineered	  an	  alternative	   construct	   for	   FtsA,	   sfGFP-­‐FtsA51.	   The	   sequence	   of	   FtsA	   in	   this	  construct	   is	   the	   wild-­‐type	   sequence	   of	   FtsA	   from	  E.	   coli	   inserted	   in	   a	   pET15b	  vector.	   Super	   folder	   GFP	   is	   a	   protein	  with	   excellent	   properties	   of	   folding52,	   an	  important	  requirement	  to	  consider	  for	  the	  optimal	  expression	  of	  fusion	  proteins	  with	   fluorescent	  proteins.	  The	  peculiarity	  of	   this	   construct	   is	   the	  presence	  of	   a	  linker	  made	   of	   6	   amino	   acids	   (GSGSGS)	   between	   the	   sGFP	   and	   FtsA.	   In	   fusion	  proteins,	   the	  presence	  of	  a	   flexible	   linker	  made	  of	  amino	  acids,	   such	  as	  glycine	  and	  serine,	  can	  help	  the	  folding	  of	  both	  the	  proteins.	  We	  followed	  two	  different	  approaches	  to	  realize	  sfGFP-­‐FtsA.	  We	  tried	  in	  a	  first	  moment	  to	  obtain	  sfgfp	  fused	  with	  ftsA	  by	  overlapping	  PCR	  but	  we	  failed,	  so	  we	  subcloned	  separately	  sfgfp	  and	  
ftsA	  in	  pET28b.	  The	  overlapping	  PCR	  is	  an	  ideal	  protocol	  to	  attach	  two	  separate	  PCR	   products	   together.	   The	   primers	   are	   designed	   in	   order	   to	   have	   a	   short	  overlap	  of	  complementary	  sequence	  (typically	  30	  –	  60	  bp).	  The	  overlap	  can	  be	  produced	   by	   the	   addition	   of	   bases	   to	   the	   ends	   of	   the	   internal	   primers	   for	   the	  respective	  PCR	  products.	   The	   combination	   of	   the	   two	  PCRs	  products	   produces	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the	  fusion	  between	  the	  two	  genes.	  The	  fusion	  between	  the	  two	  genes	  of	  interest	  can	  be	  subcloned	  in	  the	  vector	  of	  interest.	  	  
	  We	  amplified	  successfully	  ftsA,	  present	  in	  pET15b	  vector	  and	  sgfp	  (Fig.3.6)	  present	  in	  pSB1A2	  vector	  by	  Phusion	  High-­‐Fidelity	  DNA	  polymerase.	  The	  Phusion	  High-­‐Fidelity	  DNA	  polymerase	  is	  a	  polymerase	  with	  5’→3’	  DNA	  polymerase	  activity	  and	  3’→5’	  exonuclease	  activity.	  Two	  buffers	  are	  provided	  with	  Phusion	  High-­‐Fidelity	  DNA	  Polymerase:	  5x	  Phusion	  HF	  Buffer	  and	  5x	  Phusion	  GC	  Buffer.	  The	  error	  rate	  of	  Phusion	  DNA	  Polymerase	  in	  HF	  Buffer	  (4.4	  x	  10-­‐7)	  is	  lower	  than	  that	  in	  GC	  Buffer	  (9.5	  x	  10-­‐7).	  Therefore,	  the	  HF	  Buffer	  should	  be	  used	  as	  buffer	  for	  high	  fidelity	  amplification.	  However,	  GC	  Buffer	  can	  improve	  the	  performance	  of	  Phusion	  DNA	  Polymerase	  with	  GC-­‐rich	  templates	  or	  those	  with	  complex	  secondary	  structures.	  For	  the	  amplification	  of	  ftsA	  we	  screened	  just	  the	  HF	  buffer	  (Fig.	  3.5),	  instead	  for	  the	  amplification	  of	  sfgfp	  both	  HF	  and	  GC	  provided	  a	  good	  amplification	  (Fig	  3.6).	  Due	  to	  these	  results,	  we	  choose	  the	  Phusion	  polymerase	  as	  the	  ideal	  enzyme	  for	  the	  overlapping	  PCR.	  We	  obtained	  the	  fusion	  of	  interest	  sgfp-­‐gsgsgs-­‐ftsA	  (Fig.	  3.7)	  but	  we	  failed	  in	  subcloning	  the	  gene	  in	  pET28b.	  In	  the	  appendix	  are	  reported	  someefforts	  for	  the	  optimization	  of	  the	  overlap	  between	  the	  sgfp	  and	  ftsA	  by	  PCR	  (Fig.	  A1	  and	  A2).	  	  
 
Fig.3.5: 1%	  agarose	  gel	  electrophoresis	  TAE	  1X.	  
ftsA	  (pET15b)	  is	  properly	  amplified	  by	  Phusion-­‐High	  Fidelity	  DNA	  Polymerase	  (Thermo	  scientific)	  in	  HF	  buffer.	  The	  length	  of	  the	  gene	  is	  1263	  bp.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (NEB). 	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Fig.3.6: 1%	  agarose	  gel	  electrophoresis	  in	  TAE	  1X.	  sgfp	  (pSB1A2)	  is	  properly	  amplified	  by	  Phusion-­‐High	  Fidelity	  DNA	  polymerase	  (Thermo	  scientific)	  in	  both	  HF	  and	  GC	  buffer.	  The	  length	  of	  the	  gene	  is	  720bp.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (NEB).	  	  	  	  	  	  	  
Fig3.7: 1%	  agarose	  gel	  electrophoresis	  in	  TAE	  1X.	  	  The	  overlap	  between	  sgfp	  and	  ftsA	  is	  observed.	  The	  overlap	  is	  of	  1983bp,	  as	  shown	  by	  the	  bands	  highlighted	  with	  a	  circle.	  The	  reaction	  of	  overlapping	  extension	  was	  performed	  with	  Phusion-­‐High	  Fidelity	  DNA	  Polymerase	  (Thermoscientific)	  in	  both	  HF	  and	  GC	  buffer.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (NEB).	  	  	  	   	  	  In	  contrast	  we	  successfully	  realized	  a	  genetic	  construct	  encoding	  sfGFP-­‐FtsA	  by	  first	  sub	  cloning	  sgfp	  by	  NcoI	  and	  BamHI	  in	  pET28b	  and	  then	  ftsA	  via	  BamHI	  and	  XhoI	  in	  the	  same	  plasmid.	  The	  nucleotide	  sequence	  of	  the	  linker	  is	  GGC	  TCT	  GGT	  AGC	  GGA	  TCC.	  As	  we	  can	  notice	  in	  this	  sequence	  there	  is	  a	  site	  for	  BamHI	  that	  we	  exploited	  for	  sub	  cloning	  in	  two	  steps	  of	  the	  two	  genes	  encoding	  sfGFP	  and	  FtsA.	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We	  were	  able	  to	  produce	  a	  sufficient	  pool	  of	  fluorescent	  constructs	  for	  FtsZ	  and	  FtsA	  to	  test	  in	  vitro	  and	  in	  compartments.	  	  In	  particular,	  the	  expression	  in	  vitro	  lead	  us	  to	  consider	  the	  possibility	  of	  expressing	  a	  fluorescent	  version	  of	  FtsZ	  and	  a	  non-­‐fluorescent	  version	  of	  FtsA.	  	   In	  a	   first	  moment	  we	  were	  able	   to	  co-­‐express	   fluorescent	  FtsZ	  and	  non-­‐fluorescent	  FtsA	  inside	  compartments,	  but	  the	  co-­‐expression	  of	  FtsZ	  and	  FtsA	  did	  not	   provide	   a	   fine	   control	   for	   our	   genetically	   encoded	   system.	   With	   the	   co-­‐expression	   in	   fact,	   we	   can	   control	   the	   production	   of	   the	   proteins	   by	   just	  modulating	   the	   quantity	   of	   DNA	   to	   be	   used.	   Thus	   far	   this	   approach	   does	   not	  mimic	  the	  regulation	  of	  protein	  expression	  occurring	  in	  vivo	  and	  required	  for	  cell	  division.	   The	   E.	   coli	   genome	   offers	   suggestions	   for	   the	   fine	   control	   of	   our	  genetically	  encoded	  system.	   In	   fact,	   in	  E.	  coli	   the	  ratio	  of	  FtsZ	  versus	  FtsA	   is	  of	  4:1.	   The	   higher	   amount	   of	   FtsZ	   is	   explained	   by	   the	   fact	   that	   ftsZ	   in	   the	  E.	   coli	  genome	  overlaps	  with	   ftsQ.	   In	   the	   final	  part	  of	   the	   sequence	  of	   ftsQ	   is	   a	   strong	  ribosome-­‐	  binding	  site	  (RBS).	  The	  strong	  RBS	  corresponds	  to	  the	  Shine-­‐Dalgarno	  consensus	  sequence	  and	  controls	  the	  production	  of	  FtsZ	  53.	  	   These	  considerations	  lead	  us	  to	  engineer	  constructs	  where	  initially	  the	  expression	  of	  FtsZ	  and	  FtsA	  is	  controlled	  by	  a	  strong	  ribosome-­‐binding	  site.	  We	  realized	  three	  double	  constructs	  FtsZ-­‐YFP-­‐MinD-­‐FtsA,	  FtsZ-­‐YFP-­‐MinD-­‐R286W	  FtsA	  and	  YFP-­‐FtsZ-­‐FtsA	  .	  The	  engineering	  of	  the	  double	  constructs	  forecasts	  that	  the	  labeled	  FtsZ	  is	  under	  the	  control	  of	  the	  RBS	  of	  pET21b	  and	  the	  non-­‐fluorescent	  FtsA	  is	  under	  the	  control	  of	  a	  synthetic	  strong	  RBS	  inserted	  in	  the	  forward	  primer.	  More	  in	  detail,	  the	  strong	  RBS	  sequence	  corresponds	  to	  the	  Shine-­‐Dalgarno	  consensus	  sequence	  derived	  statistically	  from	  lining	  up	  many	  well-­‐characterized	  strong	  ribosome	  -­‐binding	  sites	  and	  has	  the	  sequence	  AGGAGG.	  The	  complementary	  sequence	  (CCUCCU)	  occurring	  at	  the	  3'-­‐end	  of	  the	  structural	  RNA	  ("16S")	  of	  the	  small	  ribosomal	  subunit	  base-­‐pairs	  with	  the	  Shine-­‐Dalgarno	  sequence	  in	  the	  mRNA	  in	  order	  to	  facilitate	  proper	  initiation	  of	  protein	  synthesis.	  The	  RBS	  of	  pET21b	  is	  placed	  7	  nucleotides	  upstream	  from	  the	  ATG	  and	  is	  exploited	  for	  control	  the	  expression	  of	  FtsZ.	  The	  expression	  of	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FtsA	  	  instead	  is	  controlled	  by	  a	  	  synthetic	  RBS	  placed	  7	  nucleotides	  before	  the	  ATG	  of	  FtsA.	  	  	  The	  gene	  encoding	  FtsZ-­‐YFP-­‐MinD	  in	  pET21b	  vector	  was	  amplified	  by	  Deep	  VentR	  polymerase	  (NEB)	  and	  Phusion	  DNA	  Polymerase.	  The	  Deep	  Vent	  Polymerase	  is	  a	  high	  fidelity	  polymerase.	  The	  fidelity	  of	  Deep	  VentR	  DNA	  Polymerase	  is	  derived	  in	  part	  from	  an	  integral	  3´→	  5´	  proofreading	  exonuclease	  activity.	  The	  amplification	  by	  Phusion	  High	  Fidelity	  DNA	  Polymerase	  was	  more	  specific	  than	  the	  amplification	  by	  Deep	  VentR	  polymerase	  (Fig	  3.8).	  	  	  	   	  
Fig	  3.8:	  	  0.8%	  agarose	  gel	  electrophoresis	  in	  TAE	  1X.	  ftsZ-­‐
yfp-­‐minD	  (1884	  bp)	  is	  amplified	  by	  Phusion	  High	  Fidelity	  	  DNA	  polymerase	  in	  both	  the	  buffers	  (HF	  and	  GC).	  ftsZ-­‐yfp-­‐minD	  is	  amplified	  also	  by	  Deep	  VentR	  ,	  but	  the	  amplification	  is	  less	  specific,	  as	  we	  can	  see	  from	  the	  extra	  bands	  in	  the	  sample.	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (Fermentas).	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FtsA	  and	  FtsA	  R286W	  from	  pET21b,	  were	  amplified	  successfully	  by	  the	  same	  polymerases	  as	  shown	  in	  figure	  3.9.	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Table	  3.1:	  A	  detailed	  description	  of	  the	  double	  constructs	  used.	  In	  red	  are	  indicated	  the	  parts	  derived	  from	  the	  pET21b	  sequence.	  T7-­‐XbaI-­‐RBS-­‐ NdeI	  site	  	  -­‐	  FtsZ	  (1-­‐368)	  -­‐	  EcoRI	  site	  -­‐	  YFP-­‐Venus	  -­‐	  MinD	  peptide	  -­‐	  STOP	  -­‐	  SacI	  site-­‐HindIII-­‐RBS-­‐A-­‐NheI-­‐T-­‐FtsA-­‐XhoI-­‐T7	  term	  T7-­‐XbaI-­‐RBS-­‐ NdeI	  site	  	  -­‐	  FtsZ	  (1-­‐368)	  -­‐	  EcoRI	  site	  -­‐	  YFP-­‐Venus	  -­‐	  MinD	  peptide	  -­‐	  STOP	  -­‐	  SacI	  site-­‐HindIII-­‐RBS-­‐A-­‐NheI-­‐T-­‐FtsA	  R286W-­‐XhoI-­‐T7	  term	  T7-­‐XbaI-­‐RBS-­‐ NdeI	  site-­‐YFP	  –FtsZ-­‐SacI-­‐SalI-­‐RBS-­‐A-­‐NheI-­‐T-­‐FtsA-­‐XhoI-­‐	  T7	  term	  	  	  Finally	  the	  pool	  of	  synthetic	  constructs	  was	  enriched	  with	  the	  sub	  cloning	  of	  FtsZ	  and	  FtsA	  without	  6xHis	  tag	  in	  pET21b.	  In	  the	  figure	  3.10	  and	  3.11	  are	  shown	  images	  of	  the	  two	  genes	  amplified	  before	  subcloning.	  We	  owned	  in	  our	  hands	  a	  sufficient	  pool	  of	  proteins	  to	  combine	  together.	  All	  the	  constructs	  obtained	  were	  confirmed	  by	  sequencing.	  	   In	  the	  Table	  A1	  of	  the	  appendix	  is	  reported	  a	  complete	  description	  of	  all	  the	  primers	  used	  for	  produce	  all	  the	  constructs	  described	  in	  this	  section.	  	  	   	  
Fig	  3.9:	  0.8%	  agarose	  gel	  electrophoresis	  in	  TAE	  1X.	  ftsA	  (1263	  bp)	  is	  	  amplified	  by	  Phusion	  High	  Fidelity	  	  DNA	  polymerase	  in	  HF	  buffer	  and	  also	  by	  Deep	  VentR	  .	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (Fermentas).	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Fig.	  3.10:	  	  ftsZ	  (1205	  bp)	  is	  amplified	  by	  Phusion	  High	  Fidelity	  DNA	  Polymerase	  in	  HF	  buffer	  and	  also	  by	  Deep	  VentR	  .	  The	  ladder	  used	  is	  a	  1kb	  ladder	  (Fermentas).	  
	  	  	  	  	  	  	  	  	  3.2.2	  In	  vitro	  expression	  of	  FtsZ	  and	  FtsA	  	   The	  expression	  in	  vitro	  of	  a	  genetically	  encoded	  system	  is	  a	  preliminary	  step	  to	  follow	  before	  the	  encapsulation	  in	  compartments	  such	  as	  phospholipids	  vesicles	  and	  w/o	  emulsions.	  The	  evaluation	  of	  the	  data	  in	  vitro	  gave	  us	  the	  opportunity	  to	  establish	  conditions	  for	  the	  expression	  in	  compartments,	  in	  terms	  of	  the	  type	  of	  T/T	  system	  to	  use	  and	  the	  parameters	  to	  set	  up,	  as	  for	  example	  time	  and	  temperature.	  The	  expression	  in	  vitro	  was	  evaluated	  by	  fluorescence	  spectroscopy	  exploiting	  the	  fluorescent	  properties	  of	  our	  constructs.	  	  FtsZ-­‐YFP-­‐MinD	  was	  expressed	  in	  vitro	  by	  E.	  coli	  extract	  (PROMEGA	  S30)	  and	  by	  the	  PURESYSTEM	  for	  6	  h	  at	  37°C	  in	  a	  cuvette	  (Fig.3-­‐1).	  The	  evaluation	  of	  the	  expression	  by	  fluorescence	  was	  possible,	  exploiting	  the	  excitation	  and	  emission	  wavelengths	  of	  the	  fluorescent	  tag,	  YFP-­‐Venus	  (Ex=515nm,Em=528	  nm),	  present	  in	  the	  construct.	  The	  protein	  was	  successfully	  produced	  by	  both	  the	  T/T	  systems,	  but	  the	  production	  was	  higher	  with	  the	  PURESYSTEM.	  The	  result	  is	  expected,	  because	  the	  PURESYSTEM	  is	  free	  of	  inhibitory	  substances	  such	  as	  nucleases,	  proteases,	  and	  enzymes	  that	  hydrolyze	  nucleotide	  triphosphate,	  so	  permits	  to	  use	  a	  low	  amount	  of	  DNA	  and	  obtain	  a	  high	  level	  of	  protein	  expression.	  After	  3h,	  from	  the	  start	  of	  the	  reaction,	  we	  noticed	  a	  significant	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increase	  of	  expression	  of	  FtsZ-­‐YFP-­‐MinD	  with	  the	  PURESYSTEM.	  
	  	  
Fig	  3.1:	  In	  vitro	  expression	  of	  FtsZ-­‐YFP-­‐MinD.	  FtsZ-­‐YFP-­‐MinD	  is	  expressed	  by	  E.	  coli	  extract	  (red	  line)	  and	  by	  PURESYSTEM	  (black	  line).	  The	  expression	  by	  PURESYSTEM	  increased	  after	  3h.	  	  	  The	   possibility	   of	   expressing	   FtsZ-­‐YFP-­‐MinD	   in	   vitro	   encouraged	   us	   to	  express	   also	   YFP-­‐FtsZ.	   The	   yellow	   fluorescent	   protein	   in	   this	   construct	   is	   the	  monomeric	  YPet	  (A206K	  YPet,	  Ex=517,	  Em=530).	  YFP-­‐FtsZ	  was	  expressed	  for	  6	  h	   in	   cuvette	   at	   37	   °C.	   In	   contrast	  with	   FtsZ-­‐YFP-­‐MinD,	   YFP-­‐FtsZ	  was	  produced	  more	  by	  E.	  coli	  extract	  than	  by	  PURE	  system,	  but	  both	  the	  systems	  expressed	  the	  proteins	  in	  a	  fast	  way.	  Furthermore,	  after	  approximately	  one	  hour,	  was	  possible	  to	  see	  an	   increase	  of	  production	  of	   the	  protein	  expressed	  by	  the	  PURESYSTEM.	  We	   demonstrated	   that	   transcription	   and	   translation	   in	   vitro	   of	   fluorescent	  labeled	  constructs	  is	  possible	  and	  gives	  rise	  to	  a	  good	  yield	  of	  protein.	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  Fig.3.12:	   In	   vitro	   expression	   of	   YFP-­‐FtsZ.	   YFP-­‐FtsZ	   by	   E.	   coli	   extract	   (pink	   line)	   and	   by	  PURESYSTEM	  (blue	  line).	  The	  expression	  is	  higher	  by	  E.	  coli	  extract	  than	  by	  PURESYSTEM.	  	  	   Definitively	  we	  were	  able	  to	  express	  fluorescent	  version	  for	  FtsZ	  and	  then	  we	  expressed	  fluorescent	  constructs	  for	  FtsA.	  We	  expressed	  CFP-­‐FtsA	  and	  sfGFP-­‐FtsA.	  The	  CFP	  present	  at	   the	  N-­‐terminus	  of	  FtsA	   is	  a	  monomeric	  CyPet	  (A206K	  CyPet)	   that	   has	   an	   Ex=435	  nm	   and	   an	  Em=477	  nm.	   The	   in	   vitro	   expression	   of	  CFP-­‐FtsA	   and	   of	   CFP	   R286W	   FtsA	   by	   E.	   coli	   extract,	   at	   37°C	   for	   6	   h,	   failed	  (Fig.3.3).	  In	  reality	  E.	  coli	  extract	  expresses	  the	  protein	  but	  the	  proteins	  while	  are	  expressed	   precipitate	   in	   the	   cuvette.	   For	   these	   reasons	   and	   for	   the	   problems	  encountered	   with	   the	   purification	   of	   CFP-­‐FtsA	   and	   the	   mutant	   version,	   we	  designed	  new	  constructs	  for	  FtsA.	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Fig.	   3.13:	   E.	   coli	   extract	   does	   not	  express	   properly	   CFP-­‐FtsA.	   The	  protein	   is	   expressed	   but	   during	   the	  expression	  precipitates	   and	  does	   not	  fold	  properly.	  	  	  	  	  	  	   	  
Fig.	   3.14:	   E.	   coli	   extract	   does	   not	  express	   properly	   CFP-­‐FtsA	   R286W.	  The	   protein	   is	   expressed	   but	   during	  the	   expression	   precipitates	   and	   does	  not	  fold	  properly.	  	  	   	  	  	  	  	  
At	  this	  point	  an	  evaluation	  of	  the	  biochemical	  nature	  of	  FtsA	  was	  necessary	  for	  the	  understanding	  of	  the	  proper	  conditions	  to	  set	  up	  for	  the	  expression	  of	  a	  fluorescent	  constructs	  of	  FtsA.	  FtsA	  is	  not	  a	  membrane	  protein	  but	  interacts	  with	  the	  membrane	  and	  the	  overexpression	  in	  vivo	  gives	  rise	  to	  inclusion	  bodies.	  In	  other	  words,	  the	  expression	  of	  membrane	  proteins	  or	  protein	  that	  are	  interacting	  with	  the	  membrane	  is	  challenging	  because	  their	  hydrophobic	  nature	  and	  require	  the	  evaluation	  of	  different	  strategies	  finalized	  to	  improve	  the	  process	  of	  folding54.	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The	   expression	   of	   a	   non-­‐soluble	   protein	   could	   be	   improved	   by	   co-­‐expression	  with	  an	   interaction	  partner	  protein	  or	  a	  molecular	  chaperone	  or	  by	  offering	   to	   the	   T/T	   system	   an	   artificial	   hydrophobic	   environment	   such	   as	   a	  detergent	   or	   a	   compartment55.	  An	   interaction	  partner	  protein	   is	   a	  protein	   that	  naturally	   interacts	   with	   the	   non-­‐soluble,	   i.e	   FtsA	   interacts	   with	   FtsZ	   in	   the	  divisome.	  A	  molecular	  chaperone	  is	  a	  protein	  that	  help	  the	  folding	  of	  another,	  i.e	  DnaK,	   is	   a	   protein	   that	   in	   E.	   coli	   is	   involved	   in	   the	   process	   of	   folding.	   The	  reconstruction	   of	   a	   hydrophobic	   environment	   for	   the	   in	   vitro	   T/T	   system	  forecasts	   the	  use	  of	  mild	  detergents	  otherwise	  detergents	   that	   keep	   the	  native	  structure	   of	   the	   protein,	   or	   the	   direct	   expression	   inside	   w/	   o	   emulsions	   and	  vesicles.	  	   In	  our	  case	  we	  evaluated	  that	  E.	  coli	  extract	  is	  the	  ideal	  T/T	  system	  for	  the	  expression	  of	  FtsA,	  because	  the	  extract	  contains	  chaperones	  that	  help	  the	  folding	  of	   the	   protein.	   The	   sequence	   of	   FtsA,	   in	   sfGFP-­‐FtsA,	   is	   the	  wild-­‐type	   sequence	  from	   E.	   coli	   and	   the	   N-­‐terminus	   is	   connected	   with	   the	   sfGFP	   through	   a	   linker	  GSGSGS.	   The	   choice	   to	   place	   a	   flexible	   linker	   between	   FtsA	   and	   sfGFP,	   was	  strategic	   in	   order	   to	   obtain	   a	   desired	   improvement	   of	   the	   folding	   of	   the	  fluorescent	  tag	  and	  FtsA.	  	  	  
E.	  coli	  extract	  (PROMEGA	  S30)	  was	  not	  able	   to	  express	  sfGFP-­‐FtsA	  at	  37	  °C	  (Fig.3.15,	  panel	  A)	  in	  a	  time	  course	  reaction	  of	  6	  h.	  sfGFP	  (Ex=485,	  Em=510)	  as	   mentioned	   before,	   has	   excellent	   properties	   of	   folding54	   but	   although	   this	  natural	   features	   and	   the	   presence	   in	   E.	   coli	   extract	   of	   factors	   involved	   in	   the	  process	  of	  folding,	  the	  expression	  of	  sfGFP-­‐FtsA	  was	  challenging.	  For	  this	  reason	  we	   evaluated	   to	   follow	   some	   of	   the	   strategies	   described	   before.	   We	   tried	   to	  express	   sfGFP-­‐FtsA	   with	   FtsZ	   (Fig.3.15,	   panel	   C)	   in	   the	   presence	   of	   a	   mild	  detergent,	  such	  as	  Triton	  X	  -­‐100	  at	  0.1%	  vol/vol	  (Fig.3.15,	  panel	  B)	  and	  in	  w/o	  emulsions	   (Fig.3.15,	   panel	   C).	  We	   did	   not	   have	   success,	   but	   in	   comparison	   the	  expression	   in	   w/o	   emulsion	   (3.19)	   gave	   some	   slight	   improvements.	   All	   the	  negative	  attempts	  of	  expression	  of	  fluorescently	  labeled	  versions	  of	  FtsA	  lead	  us	  to	  consider	  non-­‐fluorescently	  labeled	  versions	  of	  FtsA	  for	  our	  system.	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Fig	  3.15:	  sfGFP-­‐FtsA	  is	  not	  expressed	  properly	  by	  E,	  coli	  extract	  (panel	  A)	  in	  the	  presence	  of	  0.1	  %	   vol/vol	   Triton	   X-­‐100	   (B)	   and	   of	   the	   interaction	   partner	   protein,	   FtsZ	   (C).	   The	   expression	   is	  slightly	  improved	  when	  performed	  in	  w/o	  emulsion.	  	  	   We	  decided	  to	  express	  in	  our	  system	  a	  non-­‐fluorescently	  labeled	  version	  of	  FtsA,	  so	  we	  needed	  to	  demonstrate	   that	  FtsA	  was	  effectively	  produced	  by	   in	  
vitro	   T/T.	   We	   radiolabeled	   FtsA,	   performing	   reactions	   of	   T/T	   in	   vitro	   in	   the	  presence	  of	  S35,	  which	  is	  incorporated	  in	  the	  protein	  during	  its	  production,	  then	  just	   5	   µL	   of	   the	   reaction	   product	   were	   loaded	   on	   a	   SDS	   gel	   at	   10%.	   The	  radioactivity	  confirmed	  that	  FtsA	  is	  expressed	  by	  in	  vitro	  T/T	  PURESYSTEM	  and	  also	  that	  YFP-­‐FtsZ	  and	  FtsZ-­‐YFP-­‐MinD	  were	  successfully	  expressed.	  We	  did	  not	  have	   in	   our	   hands	   a	   radioactively	   labeled	   ladder,	   so	   we	   labeled	   the	   bands	  correspondent	   to	   the	   molecular	   weight	   of	   our	   interest	   with	   few	   µL	   of	   S35,	   in	  order	  to	  verify	  the	  MW	  of	  our	  proteins.	  FtsA	  has	  a	  MW	  of	  42	  kDa,	  FtsZ-­‐YFP-­‐MinD	  of	  70.2	  kDa	  and	  YFP-­‐FtsZ	  of	  70.4	  kDa.	  Further	  we	  tested	  also	  the	  expression	  of	  CFP-­‐FtsA	  and	  CFP	  R286W	  (MW=	  75.7	  kDa)	  	  and	  of	  sfGFP-­‐FtsA.	  sfGFP-­‐FtsA	  is	  not	  expressed	  by	  PURESYSTEM	  .	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Fig	  3.17:	  PURESYSTEM	  expresses	  FtsA,	  	  YFP-­‐FTsZ,	   CFP-­‐FtsA	   and	  CFP-­‐R286W	  FtsA.	  From	   the	   left,	   lane	  B	   is	   expression	  of	   FtsA	  (42KDa,number	   of	  Methionines=9),	   lane	   C	  of	   YFP-­‐FtsZ	   (70,2KDa,	   Met=21)	   lane	   D	   of	  CFP-­‐FtsA	   (75.7KDa,Met=20)	   and	   lane	   E	   of	  CFP-­‐FtsA	   R286W	   (75.7KDa,Met=20).	  sfGFP-­‐gsgsgs-­‐FtsA(72KDa)is	  not	  expressed	  by	   PURESYSTEM.	   LaneA	   is	   the	   protein	  ladder	   10-­‐250	   kDa	   with	   MW=70	   kDa	  labeled	  with	  2µL	  of	  S35.	  	  	  	  	   Instead,	   for	   CFP-­‐FtsA	   and	   CFP	   R286W	   FtsA,	   that	   were	   not	   properly	  expressed	   by	   E.	   coli	   extract	   in	   vitro,	   we	   had	   the	   opportunity	   to	   confirm	   by	  radioactivity	   that	   these	   proteins	   are	   expressed,	   simply	   by	   performing	   the	  reaction	  with	  the	  PURESYSTEM	  (Fig.	  3.17).	  Furthermore,	  as	  shown	  in	  figure	  3.18,	  we	   were	   able	   to	   express	   CFP-­‐FtsA	   inside	   phospholipid	   vesicles	   (DOPG:	   PC,	  20:80).	   The	   vesicles	   were	   prepared	   following	   the	   Yomo	  method56,	   hydratated	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Fig	   3.18:	   CFP-­‐FtsA	   is	   expressed	  by	  PURESYSTEM	   in	  phospholipids	   vescicles,	  DOPG:	  PC,	   20:80.	  The	  expression	  was	  evaluated	  by	  fluorescence	  microscopy	  and	  CFP	  (CyPet)	  fluorescence	  is	  false	  colored	  in	  cyan.	  Is	  possible	  to	  see	  fluorescence	  after	  2	  h	  of	  incubation	  of	  the	  vescicles	  at	  37	  °C.	  	  	  3.	  2.3	  Expression	  in	  vesicles	  and	  in	  w/o	  emulsions.	  	   Once	   we	   confirmed	   the	   possibility	   of	   expression	   in	   vitro	   of	   these	  constructs	  by	  T/T,	  we	  proceeded	  with	  the	  expression	  in	  w/	  o	  emulsions.	  At	  the	  beginning	  we	  co-­‐expressed	  two	  proteins	  at	  same	  time	  and	  then	  we	  moved	  to	  the	  expression	  of	  constructs	  containing	  both	  the	  proteins	  of	  interest	  (Fig.	  3.8).	  	  	  	  
	  
	  



















Fig.	   3.18	   FtsZ-­‐YFP-­‐MinD	   is	   expressed	   by	   E.	   coli	   extract	   and	   encapsulated	   in	   w/o	   emulsions	  (panel	  A).	  Scale	  bar	  is	  8	  µm.	  FtsZ-­‐YFP-­‐MinD	  and	  FtsA	  (panel	  B)	  are	  co-­‐expressed	  by	  E.	  coli	  extract	  and	  assemble	  in	  ring-­‐like	  structures.	  Scale	  bar	  is	  5	  µm.	  Fluorescent	  YFP	  Venus	  is	  false	  colored	  in	  yellow.	  YFP-­‐FtsZ	  (panel	  C)	  is	  expressed	  by	  E.	  coli	  extract.	  Scale	  bar	  is	  10	  µm.	  YFP-­‐FtsZ	  and	  FtsA	  are	  coexpressed	  (panel	  D)	  by	  the	  same	  T/T	  system,	  forming	  ring-­‐like	  structure.	  Fluorescent	  YFP,	  YPet,	  is	  false	  colored	  in	  green.	  Scale	  bar	  is	  12	  µm.	  	   	  The	  co-­‐expression	  of	  FtsZ	  and	  FtsA,	  as	  already	  mentioned	  before,	  does	  not	  provide	  a	  fine	  control	  for	  our	  genetically	  encoded	  system.	  We	  need	  a	  fine	  control	  for	  the	  expression	  of	  the	  proteins	  of	  our	  system,	  taking	  in	  account	  that	  in	  E.	  coli	  the	  ratio	  of	  FtsZ	  versus	  FtsA	  is	  of	  4:1.	  The	  modulation	  of	  the	  strength	  of	  the	  RBS	  sites	  could	  regulate	  the	  ratio	  of	  the	  two	  proteins	  in	  our	  system.	  In	  a	  first	  attempt	  we	  engineered	  constructs	   for	  FtsZ	  and	  FtsA	  under	   the	  control	  of	  a	   strong	  RBS.	  The	   constructs	   realized	   are	   FtsZ-­‐YFP-­‐MinD-­‐FtsA	   and	   YFP-­‐FtsZ-­‐FtsA.	   We	  expressed	   all	   these	   constructs	   in	  w/o	   emulsions	   and	   in	   phospholipids	   vesicles	  using	  E.	  coli	  extract	  (PROMEGA	  S30)	  and	  PURESYSTEM	  as	  systems	  of	  expression	  (Fig.	   3.20).	   Both	   the	   two	   system	   in	   vitro	   T/T	   gave	   good	   level	   of	   expression	   of	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proteins	  (Fig	  3.19	  and	  Fig.	  3.20).	  The	  constructs	  used	  were	  not	  designed	  with	  His	  tags,	  so	  non-­‐specific	  binding	  of	  the	  proteins	  to	  the	  compartments	  is	  not	  expected.	  	  	  	  The	   expression	   of	   YFP-­‐FtsZ-­‐FtsA	   R286W	   in	   w/o	   emulsions	   did	   not	  provide	   significant	   results.	   The	   co-­‐expression	   of	   FtsZ	   and	   FtsA,	   as	   already	  mentioned	   before,	   does	   not	   provide	   a	   fine	   control	   for	   our	   genetically	   encoded	  system.	  We	  need	  a	  fine	  control	  for	  the	  expression	  of	  the	  proteins	  of	  our	  system,	  taking	   in	   account	   that	   in	   E.	   coli	   the	   ratio	   of	   FtsZ	   versus	   FtsA	   is	   of	   4:1.	   The	  modulation	  of	   the	   strength	  of	   the	  RBS	  sites	   could	   regulate	   the	   ratio	  of	   the	   two	  proteins	  in	  our	  system.	  In	  a	  first	  attempt	  we	  engineered	  constructs	  for	  FtsZ	  and	  FtsA	   under	   the	   control	   of	   a	   strong	   RBS.	   The	   constructs	   realized	   are	   FtsZ-­‐YFP-­‐MinD-­‐FtsA	   and	   YFP-­‐FtsZ-­‐FtsA.	   We	   expressed	   all	   these	   constructs	   in	   w/o	  emulsions	   and	   in	   phospholipids	   vesicles	   using	   E.	   coli	   extract	   (PROMEGA	   S30)	  and	  PURESYSTEM	  as	  systems	  of	  expression	  (Fig.	  3.20).	  Both	   the	   two	  system	  in	  
vitro	  T/T	  gave	  good	  level	  of	  expression	  of	  proteins	  (Fig	  3.19	  and	  Fig.	  3.20).	  The	  constructs	  used	  were	  not	  designed	  with	  Histidine	  tags,	  so	  non-­‐specific	  binding	  of	  the	  proteins	   to	   the	  compartments	   is	  not	  expected.	  The	  expression	  of	  YFP-­‐FtsZ-­‐FtsA	  R286W	  in	  w/o	  emulsions	  did	  not	  provide	  significant	  results.	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Fig.	  3.19:FtsZ-­‐YFP-­‐MinD	  (panel	  A)	  is	  expressed	  by	  E.	  coli	  extract	  and	  does	  not	  form	  ring	  like	  structure.	  FtsZ-­‐YFP-­‐MinD-­‐FtsA,	  in	  panel	  B	  is	  expressed	  by	  E.	  coli	  extract	  and	  forms	  ring	  like	  structure.	  The	  fluorescence	  was	  evaluated	  by	  fluorescence	  microscopy.	  The	  YFP	  (Venus)	  has	  an	  Ex=515	  nm	  and	  an	  Em=528	  nm	  and	  was	  visualized	  using	  a	  GFP	  filter	  and	  false	  colored	  in	  yellow.	  The	  production	  of	  FtsZ-­‐YFP-­‐MinD	  in	  the	  w/o	  emulsion	  show	  that	  the	  protein	  forms	  aggregates	  spread	  in	  the	  compartments.	  Scale	  bar	  is	  22	  mm.	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Fig.3.20:	   From	   the	   top	   FtsZ-­‐YFP-­‐MinD	   is	   expressed	   by	   PURESYSTEM	   in	   w/o	   emulsions.	   The	  protein	  is	  expressed	  and	  forms	  aggregates	  in	  the	  emulsions.	  The	  expression	  of	  the	  YFP	  (Venus)	  is	  false	  colored	  in	  yellow.	  FtsZ-­‐YFP-­‐MinD-­‐FtsA	  is	  expressed	  by	  PURESYSTEM	  in	  w/o	  emulsions	  and	  forms	   ring-­‐like	   structure.	   The	   fluorescence	   was	   evaluated	   by	   fluorescence	   microscopy	   The	  YFP(Venus)	  has	  an	  Ex=515	  nm	  and	  an	  Em=528	  nm	  and	  was	  visualized	  using	  a	  GFP	  filter.	  Scale	  bar	  is	  22	  µm.	  	   	  In	   general,	   the	   expression	   of	   these	   constructs	   was	   evaluated	   by	  fluorescence	   microscopy.	   When	   YFP-­‐FtsZ	   and	   FtsZ-­‐YFP-­‐MinD	   are	   expressed	  alone,	  they	  do	  not	  assemble	  together	  forming	  ring-­‐like	  structure.	  In	  the	  presence	  of	  FtsA	  we	  noticed	  formation	  of	  ring-­‐like	  structure	  that	  do	  not	  have	  the	  ability	  of	  constrict	  the	  droplets.	  A	  possible	  way	  for	  explain	  the	  lack	  of	  constriction	  force	  is	  the	  fact	  that	  the	  droplets	  have	  round	  shape,	  while	  E.	  coli	  has	  instead	  is	  tubular.	  
	  	   54	  
Ericksson	   and	   colleagues	   exploited	   multi	   lamellar	   and	   tubular	   liposomes	   and	  were	  able	  to	  observe	  constriction	  mediated	  by	  FtsZ-­‐YFP-­‐MinD.	  	   We	   developed	   a	   self-­‐sustainable	   compartment	   able	   to	   produce	  fluorescently	  tagged	  proteins	  that	  polymerize	  and	  form	  rings	  in	  w/o	  emulsions.	  The	  experiments	  were	  repeated	  several	  times	  and	  every	  time,	  in	  the	  presence	  of	  FtsA,	   it	  was	  possible	   to	   observe	   the	   formation	  of	   rings.	   In	   order	   to	   get	   a	  more	  robust	  system	  we	  co-­‐expressed	  YFP-­‐FtsZ-­‐FtsA	  and	  a	  non-­‐fluorescent	  FtsZ.	  The	  co	  expression	  of	  YFP-­‐FtsZ-­‐FtsA	  with	  FtsZ	  lead	  to	  bigger	  rings	  (Fig.	  3.20).	  The	   fact	   that	   bigger	   rings	  were	   formed	   confirmed	   that	   the	   rings	   are	   real,	   even	  though	   constriction	   was	   never	   observed.	   An	   enrichment	   of	   the	   system	   was	  possible	   and	   a	   minimal	   synthetic	   division	   machinery	   system	   was	   realized	  assembling	  biological	  parts	  from	  the	  scratch.	  	   Furthermore	  we	   synthesized	   our	  minimal	   division	  machinery	   system	   in	  phospholipids	   vesicles.	   The	   vesicles,	   made	   of	   PC:	   DOPG	   80:20	   were	   prepared	  following	  the	  Yomo	  method56,	  mentioned	  before	  and	  described	  in	  the	  Materials	  and	   Methods	   section.	   The	   formation	   of	   the	   rings	   in	   the	   presence	   of	   FtsA	   was	  more	  difficult	  to	  be	  evaluated	  in	  vesicles.	  	  Herein	  we	  report	  just	  the	  images	  that	  show	   a	   more	   relevant	   expression	   of	   the	   protein	   of	   interest.	   The	   figure	   3.21	  showed	   that	   the	   proteins	   YFP-­‐FtsZ-­‐FtsA	   and	   FtsZ	   are	   expressed	   by	   the	  PURESYSTEM	  inside	  of	  vesicles	  and	  form	  ring-­‐like	  structure.	  In	  order	  to	  exclude	  the	  possibility	  that	  lipid	  artifacts	  could	  form	  the	  rings,	  we	  will	  need	  to	  test,	  in	  the	  future,	   different	   lipids	   compositions	   and	   express	   different	   combinations	   of	  proteins.	  	  	  	  
	  
	  






































Fig.	  3.21:	  YFP-­‐FtsZ	  (A)	  is	  expressed	  by	  E.	  coli	  extract	  and	  does	  not	  form	  ring-­‐like	  structure	  (A)	  In	   panel	   A	   YFP-­‐FtsZ-­‐FtsA	   is	   expressed	   by	   E.	   coli	   extract	   and	   form	   ring-­‐like	   structure.	   The	  expression	  was	   evaluated	  by	   fluorescence	  microscopy.	   The	  YFP	   (YPet)	   has	   an	  Ex=	  517	   and	   an	  Em=	   330	   is	   false	   colored	   in	   green	   and	   visualized	   by	   using	   a	   GFP	   filter.	   Scale	   bar	   is	   10	   µm.	  Magnification	  is	  63	  X.	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  Fig.	   3.22:	   YFP-­‐FtsZ	   co-­‐expressed	  with	   FtsZ	   give	   rise	   to	   big	   rings	   in	  w/o	   emulsions.	   YFP-­‐FtsZ-­‐FtsA	   (A)	   is	   expressed	   by	   E.	   coli	   extract	   and	   form	   ring-­‐like	   structures.	   YFP-­‐FtsZ	   -­‐FtsA,	   co	  expressed	  in	  w/o	  emulsion	  by	  E.	  coli	  extract	  give	  rise	  to	  bigger	  rings	  (panel	  B)	  is	  expressed	  by	  E.	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3.3	  Materials	  and	  Methods	  
	  
	  3.3.1	  Bacterial	  strains	  and	  plasmids.	  	   The	  bacterial	  strains	  used	  for	  the	  amplification	  of	  the	  plasmids	  of	  interest	  were	  E.	   coli	   Novablue	   or	  DH5alpha.	   A	   description	   of	   the	   strains	   is	   reported	   in	  table	  3.1.	  The	  genes	  coding	  for	  FtsZ-­‐YFP-­‐MinD,	  YFP-­‐FtsZ,	  CFP-­‐FtsA,	  CFP-­‐R286W	  FtsA	   were	   synthesized	   by	   Genscript	   in	   pUC57.	   The	   gene	   coding	   for	   sGFP	  (BBa_I746916)	   was	   taken	   from	   the	   registry	   of	   standard	   biological	   parts	  (http://partsregistry.org)	  and	  was	  contained	  in	  pSB1A2	  vector.	  The	  sequence	  of	  FtsA	   in	   sGFP-­‐FtsA	   is	   the	   wild-­‐type	   sequence	   from	   E.	   coli	   in	   pET15b.	   The	  sequences	  of	  FtsZ	  and	  FtsA	  in	  the	  double	  constructs,	  FtsZ-­‐YFP-­‐MinD-­‐FtsA,	  YFP-­‐FtsZ-­‐FtsA	  and	  YFP-­‐FtsZ-­‐R286W	  FtsA,	  are	  synthetic	  like	  the	  sequence	  of	  FtsZ	  and	  FtsA	  without	  the	  6Hisx-­‐tag	  subcloned	  in	  pET21b.	  	  Table	  3.1:	  E.	  coli	  strains	  description.	  DH5-­‐alpha	   F-­‐	  endA1	  glnV44	  thi-­‐1	  recA1	  relA1	  gyrA96	  deoR	  nupG	  Φ80dlacZΔM15	  Δ(lacZYA-­‐argF)U169,	  hsdR17(rK-­‐	  mK+),	  λ-­‐nalidixic	  acid	  resistant	  
NovaBlue	   endA1	   hsdR17(rK12-­‐	   mK12+)	   supE44	   thi-­‐1	  recA1	   gyrA96	   relA1	   lac	   F'[proA+B+	   lacIqΔM15	  ::Tn10(TetR)])Tethracycline	  resistant.	  	  
	  3.3.2	  PCR	  amplification	  and	  subcloning	  of	  FtsZ	  and	  FtsA	  constructs.	  	  	   All	   the	  genes	   coding	   for	   fluorescent	  and	  non-­‐fluorescent	  version	  of	  FtsZ	  and	  FtsA	  were	  amplified	  by	  PCR	  and	  subcloned	  in	  pET21b	  or	  in	  pET28b,	  in	  the	  case	  of	  the	  gene	  encoding	  for	  sfGFP-­‐FtsA.	  The	  program	  used	  for	  the	  amplification	  of	  the	  genes	  amplified	  by	  Taq	  DNA	  Polymerase	  (RBC),	  Hot	  Start	  DNA	  Polymerase	  (NEB)	  and	  Deep	  Vent	  Polymerase	  is	  reported	  in	  table	  3.2.	  In	  table	  3.3	  is	  reported	  instead	   the	   program	   used	   for	   the	   amplification	   by	   Phusion	   High	   Fidelity	   DNA	  polymerase.	   The	   polymerases	   used	   within	   the	   annealing	   temperature	   and	   the	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extension	  time	  exploited,	  for	  the	  amplification	  of	  each	  construct	  are	  reported	  in	  table	  3.3.	  
	  
Table	  3.2:PCR	  program	  used	  with	  Taq	  DNA	  polymerase,	  Hot	  Start	  Taq	  DNA	  polymerase	  and	  Deep	  Vent	  DNA	  Polymerase.	  	  	  	  	  
Initial	  Denaturation	   95	   1-­‐3	   1	  
Denaturation	   95	   0.5	   25-­‐40	  
Annealing	   Tm-­‐5	   0.5	   25-­‐40	  
Extension	   72	   1	  min/kb	   25-­‐40	  
Final	  Extension	   72	   5-­‐15	   1	  	  
Table	  3.3:	  PCR	  program	  for	  the	  amplification	  of	  plasmidic	  DNA	  by	  Phusion	  High	  Fidelity	  DNA	  polymerase.	  
Cycle	  step	  
2-­‐step	  
protocol	   	  
3-­‐step	  
protocol	   	  
cycles	  
	   temp	  (oC)	   time	  (s)	   temp	  (oC)	   time	  (s)	   	  
Initial	  
denaturation	  
98	   30	   98	   30	   1	  
Denaturation	   98	   5-­‐10	   98	   5-­‐10	   25-­‐35	  
Annealing	   -­‐	   -­‐	   X	   10-­‐30	   25-­‐35	  
Extension	   72	   15-­‐30	  s/1	  kb	   72	   15-­‐30	  s/1	  kb	   25-­‐35	  
Final	  
extension	  
72	   10	  min	   72	   10	  min	   1	  
End	   4	   hold	   4	   hold	   1	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After	   amplification	   the	   DNA	   was	   digested	   by	   restriction	   digestions	  (Table.3.3)	   and	   ligated	   in	   the	   vector	   of	   interest	   using	   T4	   DNA	   Ligase	   (NEB	   or	  Fermentas).	  
	  
Table	   3.4:	   DNA	  Polymerases,	   restriction	   enzymes	   employed	   and	   details	   about	  annealing	  temperature	  and	  extension	  time	  for	  each	  construct.	  
Construct	   Polymerases	   Annealing	  and	  Extension	   Restriction	  
Enzymes	  FtsZ-­‐YFP-­‐MinD	   Taq,	  Hot	  Start	  Taq	   Ann=61.2°C	  Ext=2:30	  min	   NdeI,	  XhoI	  YFP-­‐FtsZ	   Taq,	  Hot	  Start	  Taq	   Ann=61.1°C	  Ext=2:01	   NdeI,	  BamHI	  CFP-­‐FtsA	   Taq,	  Hot	  Start	  Taq	   Ann=58.4°C	  Ext=2:07	  min	   NdeI,	  BamHI	  CFP	  R286W-­‐FtsA	   Taq,	  Hot	  Start	  Taq	  	   Ann=58.4°C	  Ext=2:07	  min	   NdeI,	  BamHI	  sGFP	   Phusion	  	   Ann=	  Up	  to	  72°C	  (Two	  step	  protocol)	  Ext=11	  s	  
NcoI,	  BamHI	  
FtsA	   Phusion	   Ann=70.3	  Ext=19s	   BamHI,	  XhoI	  
RBS-­‐FtsZ-­‐YFP-­‐MinD	   Phusion,	  DeepVentR	   Ann=65°C	  	  Ext=28	  s	  Ann=60°C	  Ext=113s	  	   NdeI,	  SacI	  	  
RBS-­‐FtsA	   Phusion,	  DeepVentR	   Ann=69	  °C	  Ext=19s	  	  Ann=64	  °C	  Ext=1.2	  min	   SacI,	  XhoI	  
RBS-­‐	  	   Phusion,	  DeepVentR	   Ann=	  68	  °C	  Ext=28.3	  s	  Ann=63	  °C	  	  	  	  Ext=1.9	  min	   NdeI,	  SacI	  	  RBS-­‐FtsA	   Phusion	   Ann=68	  °C	  	  	  	  Ext=19	  s	   SacI,	  XhoI	  
FtsZ	   Phusion,	  DeepVentR	   Ann=66.8°C	  	  	  	  Ext=18	  s	  Ann=61.°C	  	  	  	  	  	  	  Ext=1.2	  min	   NdeI,	  BamHI	  
FtsA	   Phusion,	  DeepVentR	   Ann=68	  °C	  	  	  	  Ext=19	  s	  sAnn=63	  °C	  	  	  	  Ext=1.9	  min	   NdeI,	  BamHI	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3.3.3	  Transcription-­‐translation	  reactions	  in	  vitro.	  	  
	  
	  Plasmids	  were	   amplified	   by	  E.	   coli	   DH5alpha	   or	  NovaBlue	   and	   purified	  with	  Wizard	  Plus	  SV	  Minipreps	  DNA	  Purification	  System	  (Promega)	  or	  QIAprep	  Spin	   Miniprep	   Kit	   (Qiagen).	   	   Subsequently,	   the	   DNA	   was	   phenol-­‐chloroform	  extracted,	   ethanol	   precipitated,	   and	   resuspended	   in	   deionized	   and	  diethylpyrocarbonate	  (DEPC)	  treated	  water.	  1µg	  of	  DNA	  was	  used	  in	  the	  case	  of	  transcription-­‐translation	   reaction	   with	   E.	   coli	   extract	   (PROMEGA	   S30)	   both	   in	  case	  of	  expression	  of	  a	   single	  gene	   that	   in	   case	  of	   co-­‐expression.	  The	   reactions	  were	  supplied	  with	  40	  units	  of	  RNAse	  inhibitor	  from	  human	  placenta	  (NEB).	  250	  ng	   DNA	   were	   used	   for	   each	   transcription-­‐translation	   reaction	   with	   the	  PUREXPRESS	  in	  vitro	  protein	  synthesis	  kit	  (NEB)	  supplemented	  with	  20	  units	  of	  human	   placenta	   RNase	   inhibitor	   (NEB)	   The	   reaction	   components	   were	  assembled	  on	  ice	  and	  then	  incubated	  at	  37	  °C	  in	  the	  spectrophotometer	  in	  case	  of	  in	  vitro	   expression	   for	   6	  h,	   directly	   inside	  w/o	   emulsion	   and	  vesicle	   in	   case	   of	  expression	  in	  compartments	  for	  approximately	  2	  h.	  	  	  3.3.4	  Radioactive	  labeling	  of	  proteins	  expressed	  in	  vitro	  	   The	   proteins	   YFP-­‐FtsZ,	   FtsZ-­‐YFP-­‐MinD,	   FtsA,	   CFP-­‐FtsA	   and	   CFP-­‐R286W	  FtsA	  were	  labeled	  by	  adding	  20	  µCi	  of	  S-­‐35	  (purchased	  from	  Perkin	  Elmer)	  to	  the	  reaction	   of	   T/T	   of	   PURESYSTEM.	   The	   reactions	   were	   assembled	   as	   described	  before.	  After	  the	  addition	  of	  the	  plasmidic	  DNA,	  the	  reaction	  was	  incubated	  for	  2	  h	   at	   37	   °.	   Just	   5	  µL	   of	   reaction	  were	   loaded	   on	   a	   SDS	   gel	   at	   10%.	   The	   protein	  ladder	  used	  is	  a	  Page	  Ruler	  Plus	  Prestained	  Ladder	  (10-­‐250	  kDa)	  purchased	  from	  Fermentas	  in	  which	  some	  of	  the	  bands	  were	  labeled	  with	  2	  µL	  S35	  (by	  painting).	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3.3.5	  W	  /o	  emulsions	  
	  The	  oil	  phase	  was	  freshly	  prepared	  by	  mixing	  4.5%	  (vol/vol)	  Span	  80	  and	  0.5	  %	  (vol/vol)	  Tween	  80	  in	  0.95	  mL	  of	  mineral	  oil.	  This	  mixture	  was	  vortexed	  until	  the	  Span	  80	  was	  completely	  dissolved	  in	  the	  mineral	  oil.	  0.05	  mL	  of	  reaction	  in	   case	  of	  E.	  coli	  extract	   and	  0.025	  mL	   for	  PURESYSTEM	  were	  added	   to	   the	  oil	  phase	  and	  vortexed	  vigourosly	  until	  the	  solution	  became	  turbid.	  
	  	  3.3.6	  Vesicles	  preparation	  
 Vesicles	   were	   made	   with	   1,2-­‐dioleoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐(1'-­‐rac-­‐glycerol)	  (sodium	  salt)	  (DOPG)	  purchased	  from	  Sigma,	  L-­‐α-­‐phosphatidylcholine	  from	  egg	  yolk	  (egg	  lecithin)	  (Sigma),	  using	  a	  method	  similar	  to	  that	  described	  by	  Yomo	  and	  colleagues56.	  Lipid	  stocks	  were	  made	  by	  dissolving	  1	  g	  DOPG	  in	  25	  mL	  chloroform	  to	  obtain	  a	  40mg/mL	  solution.	  Similarly,	  a	  20	  mg/mL	  lecithin	  stock	  was	  prepared	  by	  dissolving	  400	  mg	   lecithin	   in	  20	  mL	  chloroform.	  With	  a	  glass	  pipette,	  lipids	  were	  transferred	  to	  a	  round	  bottom	  flask.	  The	  organic	  solvent	  was	  then	   evaporated	   with	   a	   Buchi	   Rotovapor	   R-­‐210	   for	   30	   min.	   This	   procedure	  resulted	  in	  a	  thin	  lipid	  film	  inside	  of	  the	  round	  bottom	  flask.	  Next,	  1	  mL	  deionized	  water	  was	  added	  to	  hydrate	  the	  lipid,	  giving	  a	  concentration	  of	  12	  mM	  lipid.	  The	  liposome	   dispersion	   was	   homogenized	   with	   IKA	   T10	   basic	   homogenizer	   at	  power	   setting	  4	   for	  1	  min	  and	  extruded	  eleven	   times	   through	  a	  polycarbonate filter	  (Whatman,	  Brentford,	  UK)	  with	  a	  pore	  size	  of	  400	  nm.	  40	  μL	  aliquots	  were	  flash	   frozen	   in	   liquid	   nitrogen	   or	   dry	   ice	   and	   lyophilized	   in	   a	   SpeedVac	  (Centritrap	   DNA	   concentrator,	   Labconco)	   at	   40°C.	   The	   lyophilized	   empty	  liposomes	  were	  stored	  at	  −20	  °C.	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Chapter	  4	  
	  
Reconstitution	  of	  a	  minimal	  divisome	  with	  purified	  proteins	  in	  
compartments.	  	  4.1	  Introduction	  	   We	  aimed	  to	  synthesize	  directly	  inside	  compartments	  a	  minimal	  division	  machinery	  system	  made	  of	  FtsZ	  and	  FtsA.	  To	  our	  knowledge	  we	  are	  the	  first	  to	  attempt	   to	   build	   division	   machinery	   in	   situ.	   A	   more	   traditional	   approach,	  forecasts	  the	  direct	  encapsulation	  of	  purified	  components	  of	  the	  divisome	  inside	  compartments.	   In	   fact	   there	   are	   many	   advances,	   as	   discussed	   before,	  demonstrating	   that	   the	   reconstruction	   of	   a	   minimal	   divisome	   with	   purified	  proteins	  is	  possible.	  It	  was	  shown	  that	  FtsZ-­‐YFP-­‐MinD	  purified	  and	  encapsulated	  in	  tubular	  liposomes	  is	  able	  to	  reproduce	  the	  typical	  phenomena	  of	  cell	  division,	  that	   the	   purified	   Min	   system	   is	   able	   to	   oscillate	   and	   generate	   waves	   in	   lipid	  supported	   bilayers	   and	   that	   the	   reconstruction	   of	   proto-­‐ring	   elements	   of	   the	  divisome	   in	   liposomes	   is	   possible.	   At	   the	   beginning	   of	   this	   work	   we	   tried	   to	  reconstitute	  our	  minimal	  division	  machinery	   system	  made	  of	  FtsZ	  and	  FtsA	  by	  purifying	   some	   fluorescent	   versions	   for	   FtsZ,	   such	   as	   FtsZ-­‐YFP-­‐MinD	   and	   YFP-­‐FtsZ,	   and	   fluorescently	   labeled	   FtsA	   such	   as	   CFP-­‐FtsA	   and	   CFP	   R286W	   FtsA.	  Moreover	  FtsZ-­‐YFP-­‐MinD	  and	  YFP-­‐FtsZ	  were	  encapsulated	  in	  w/o	  emulsions	  and	  visualized	  inside	  the	  compartments	  by	  fluorescence	  microscopy.	  In	  the	  presence	  of	   guanosine	   thriphosphate	   (GTP)	   FtsZ	   formed	   aggregates	   similar	   to	   the	  polymers,	  observed	  inside	  w/o	  emulsions.	  	   	  In	   general,	   fluorescent	   versions	   of	   FtsZ	   were	   purified	   easily	   and	   were	  able	   to	  make	   polymer-­‐like	   structure	   inside	  w/	   o	   emulsions.	   In	   contrast	   to	   the	  purification	  of	  fluorescent	  constructs	  of	  FtsA,	  similarly	  to	  the	  expression	  in	  vitro,	  was	  challenging.	  The	  experimental	  approach	  followed	  for	  the	  reconstruction	  of	  a	  minimal	   division	   machinery	   system	   in	   cell-­‐like	   compartments	   with	   purified	  proteins	   will	   be	   described	   in	   the	   following	   paragraphs.	   Additionally	   the	  bottleneck	  of	  this	  approach	  will	  be	  explained.	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Fig	  4.1:	  Our	  protein	  purification	  strategy.	  Constructs	  coding	  for	  FtsZ/FtsA	  with	  tags	  of	  6	  Hisx,	  were	  expressed	  in	  E.	  coli	  BL21	  DE3/Rosetta	  and	  overexpressed	  by	  induction	  with	  IPTG.	  Then	  the	  cells	  were	  lysed	  and	  loaded	  on	  a	  Ni/NTA	  2+column.	  The	  resulting	  fractions	  were	  analyzed	  by	  SDS	  PAGE.	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FtsZ	  in	  E.	  coli	  	  is	  present	  in	  the	  cytoplasm	  or	  in	  the	  Z	  –ring.	  When	  FtsZ	  is	  part	  of	  the	  Z	  ring,	  the	  protein	  localizes	  in	  proximity	  of	  the	  inner	  cytoplasmic	  side	  of	  the	  membrane.	  FtsA,	  instead,	  is	  tethered	  to	  the	  membrane	  through	  an	  amphiphatic	  helix.	  Considering	  this	  topography	  of	  FtsZ	  and	  FtsA	  in	  vivo,	  we	  expect	  that	  FtsZ	  behaves	  as	  a	  soluble	  protein	  and	  FtsA	  as	  a	  no	  soluble	  protein.	  At	  the	  beginning	  before	  to	  set	  up	  a	  strategy	  of	  purification,	  we	  tested	  the	  solubility	  of	  the	  proteins	  after	  over-­‐expression.	  The	  over-­‐expression	  of	  the	  proteins	  occur	  after	  induction	  by	  Isopropyl-­‐Beta	  D-­‐Thiogalactopyranoside	  (IPTG).	  	  	  The	  IPTG	  binds	  to	  the	  lac	  repressor	  and	  releases	  the	  tetrameric	  repressor	  from	  the	  lac	  operator	  in	  an	  allosteric	  manner,	  thereby	  allowing	  the	  transcription	  of	  genes	  in	  the	  lac	  operon,	  such	  as	  the	  gene	  encoding	  for	  beta-­‐galactosidase,	  a	  hydrolase	  enzyme	  that	  catalyzes	  the	  hydrolysis	  of	  β-­‐galactoside	  into	  monosaccharides57.	  The	  induction	  of	  expression	  by	  IPTG	  could	  imply	  variations	  of	  the	  solubility	  of	  the	  proteins	  in	  the	  supernatant	  or	  in	  the	  pellet.	  For	  this	  reason	  we	  performed	  tests	  of	  solubility	  in	  order	  to	  understand	  the	  localization	  of	  the	  proteins	  and	  in	  order	  to	  set	  up	  a	  proper	  protocol	  for	  the	  purification	  of	  the	  same.	  	  	  	  FtsZ	  has	  a	  MW	  of	  40.2	  kDa.	  In	  absence	  of	  induction	  by	  IPTG,	  the	  amount	  of	  protein	  expressed	  in	  the	  supernatant	  is	  less	  than	  in	  the	  pellet.	  In	  contrast	  FtsZ	  is	  overexpressed	  both	  in	  the	  supernatant	  and	  in	  the	  pellet	  by	  induction	  with	  0.4	  mM	  of	  IPTG.	  (Fig.	  	  4.2).	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Fig	  4.2:	  Test	  of	  solubility	  for	  FtsZ.	  The	  MW	  is	  of	  40.2	  kDa.	  The	  protein	  is	  expressed	  both	  in	  the	  supernatant	  (B)	  and	  	  in	  the	  pellet(C).	  After	  induction	  with	  0.4	  mM	  of	  IPTG,	  the	  expression	  of	  the	  protein	  in	  the	  supernatant	  is	  increased	  (lane	  D)	  and	  even	  more	  in	  the	  pellet	  (E).	  Lane	  A	  is	  the	  protein	  ladder	  from	  10-­‐250kDa	  (NEB).	  	  	  The	  screening	  of	  the	  solubility	  of	  FtsZ	  without	  fluorescent	  tag,	  was	  useful	  to	  understand	   if	   the	   tag	   influenced	   the	  behavior	   of	   FtsZ.	  Then	   the	   solubility	   of	  YFP-­‐FtsZ	  and	  FtsZ-­‐YFP-­‐MinD	  was	  tested.	  Both	  the	  proteins	  were	  over-­‐expressed	  in	  BL21	  (DE3)	  Rosetta	  and	  a	  test	  of	  solubility	  in	  small	  scale	  was	  performed.	  The	  behavior	  of	  FtsZ	  in	  these	  constructs	  is	  not	  so	  much	  different	  from	  FtsZ	  without	  fluorescent	   tags.	  Details	   about	   the	   engineering	  of	   YFP-­‐FtsZ	   and	  FtsZ-­‐YFP-­‐MinD	  were	  described	  in	  the	  third	  chapter.	  	  	  We	   expressed	   FtsZ-­‐YFP-­‐MinD	   in	   E.	   coli	   BL21	   (DE3)	   Rosetta	   cells.	   The	  amount	  of	  protein	  in	  the	  supernatant	  after	  induction,	  compared	  with	  the	  amount	  of	   the	   protein	   before	   the	   induction	   (Fig.4.3,	   lane	   A),	   was	   increased	   after	  	  	  induction	  with	   just	  0.1	  mM	  of	  IPTG	  (Fig	  4.3,	   lane	  C).	   In	  the	  presence	  of	  0.4	  mM	  IPTG,	  the	  amount	  of	  protein	  was	  significantly	  increased	  both	  in	  the	  supernatant	  and	  in	  the	  pellet	  (Fig.4.3,	  lane	  E	  and	  lane	  F).	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Fig.4.3:	  Solubility	  of	  FtsZ-­‐YFP-­‐MinD	  after	  overexpression	  by	  IPTG.	  FtsZ-­‐YFP-­‐MInD	  has	  a	  MW	  of	  70.3	  kDa.	  Lane	  B	  is	  the	  protein	  ladder	  from	  10-­‐250	  kDa	  (NEB).	  Lane	  A	  corresponds	  to	  E.	  coli	  cells	  before	  the	  induction,	  there	  is	  non	  a	  significative	  expression	  of	  the	  protein.	  Lane	  C	  corresponds	  to	  the	   supernatant	   fraction	   after	   induction	   with	   0.1	   mM	   IPTG	   and	   lane	   E	   corresponds	   to	   the	  supernatant	   fraction	   after	   the	   induction	  with	   0.4	  mM	   IPTG.	   The	   amount	   of	   the	   protein	   in	   the	  supernatant	  is	  increased	  by	  induction	  with	  0.4mM	  IPTG.	  Lane	  D	  corresponds	  to	  the	  expression	  of	  FtsZ-­‐YFP-­‐MinD	   in	   the	   pellet	   fraction	   after	   induction	   with	   0.1	   mM	   IPTG	   and	   lane	   F	   after	   the	  induction	  with	  0.4mM	  IPTG.	  	  	   	  	  	  The	  advantage	  of	  having	  more	  protein	  in	  the	  supernatant	  facilitated	  also	  the	  process	  of	  FtsZ-­‐YFP-­‐MinD	  purification.	  	  We	  evaluated	  that	  0.1	  mM	  IPTG	  was	  a	  sufficient	  concentration	  for	  the	  overexpression	  of	  FtsZ-­‐YFP-­‐MinD.	  4	  L	  of	  expression	  were	  performed.	  Then	  the	  cells	  were	  lysed	  by	  sonication	  and	  FtsZ-­‐YFP-­‐MinD	  was	  purified	  by	  nickel	  affinity	  chromatography.	  This	  chromatography	  exploits	  the	  ability	  of	  the	  NTA	  resin	  functionalized	  with	  the	  nickel	  to	  chelate	  the	  histidines	  that	  tag	  the	  proteins.	  The	  buffer	  used	  for	  the	  equilibration	  of	  the	  column	  and	  the	  removal	  of	  the	  aspecific	  bindings	  is	  composed	  by	  50	  mM	  NaH2PO4,	  300	  mM	  NaCl,	  5	  mM	  imidazole,	  pH	  7.4	  (binding	  buffer).	  The	  column	  was	  washed	  with	  the	  same	  buffer	  plus	  20	  mM	  	  and	  60	  mM	  imidazole	  and	  the	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protein	  was	  eluted	  with	  250mM	  imidazole	  in	  binding	  buffer.	  Aliquots	  from	  the	  1st	  to	  6th	  of	  the	  elution,	  plus	  wash	  and	  flow-­‐through	  fractions	  were	  loaded	  on	  a	  SDS	  PAGE	  (Appendix,	  Fig	  A3.).	  The	  eluted	  fractions	  were	  collected	  and	  dialyzed	  in	  2	  L	  of	  50	  mM	  TrisHCl,	  50	  mM	  NaCl	  and	  1	  mM	  beta-­‐mercaptoethanol	  (BME).	  The	  MW	  of	  FtsZ-­‐YFP-­‐MinD	  is	  of	  70.2	  kDa	  and	  the	  MW	  of	  the	  imidazole	  is	  of	  0.068	  kDa,	  so	  the	  imidazole	  was	  easily	  removed	  using	  a	  Snake	  Skin	  Dialysis	  membrane	  (Thermoscientific)	  with	  7	  K	  molecular	  weight	  cut	  off	  (MWCO).	  After	  dialysis	  the	  protein	  was	  concentrated	  using	  a	  stirred	  cell	  concentrator	  supplied	  with	  an	  Amicon	  membrane	  of	  10	  KDa	  MW	  cut	  off.	  At	  the	  end	  of	  the	  chromatography	  we	  collected	  a	  volume	  of	  40	  mL	  of	  protein,	  correspondent	  to	  the	  fractions	  eluted	  from	  the	  column	  with	  a	  high	  concentration	  of	  imidazole	  (255	  mM),	  then	  the	  protein	  was	  concentrated	  to	  a	  volume	  of	  approximately	  4	  mL	  	  and	  stored	  in	  5%	  vol/vol	  glycerol.	  After	  purification	  the	  absorbance	  at	  280	  nm	  was	  measured	  by	  UV	  spectroscopy.	  The	  absorbance	  at	  280	  nm	  is	  correspondent	  to	  the	  absorption	  peak	  of	  the	  tyrosine	  and	  tryptophan	  residues	  present	  in	  the	  protein.	  We	  calculated	  the	  concentration	  of	  FtsZ-­‐YFP-­‐MinD	  using	  the	  extinction	  coefficient	  (ε) of	  YFP	  (Venus)	  at	  515	  nm,	  that	  is	  of	  92.2	  M-­‐1cm-­‐1,	  and	  the	  absorbance	  detected	  at	  515	  nm	  from	  the	  UV	  spectrum.	  We	  exploited	  the	  Beer-­‐Lambert	  law	  (A=	  εcl)	  for	  calculating	  the	  concentration.	  The	  resulting	  concentration	  was	  10.8	  µM.	  Finally,	  we	  confirmed	  the	  quality	  of	  purification	  acquiring	  excitation	  and	  emission	  scan	  of	  the	  protein	  purified.	  Venus	  YFP,	  as	  mentioned	  previously,	  has	  an	  excitation	  peak	  of	  515	  nm	  and	  an	  emission	  peak	  of	  528	  nm	  .The	  peaks	  were	  confirmed	  by	  fluorescence	  spectroscopy	  in	  our	  purified	  FtsZ-­‐YFP-­‐MinD.	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Fig.	   4.5:	   Excitation	   and	   emission	   scan	   of	   FtsZ-­‐YFP-­‐MinD	   plotted	   in	   the	   same	   graph.	   FtsZ-­‐YFP-­‐MinD	  has	  an	  excitation	  peak	  at	  515	  nm	  and	  an	  emission	  peak	  at	  528	  nm.	  The	  	  purification	  lead	  to	  the	  right	  protein.	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   After	   the	   purification	   of	   FtsZ-­‐YFP-­‐MinD	   we	   proceeded	   with	   the	  purification	   of	   YFP-­‐FtsZ.	   YFP-­‐FtsZ	   was	   expressed	   in	   E.coli	   BL21(DE3)	   Rosetta	  and	   a	   test	   of	   solubility,	   after	   the	   induction	   by	   IPTG,	   was	   performed.	  We	   over	  expressed	  YFP-­‐FtsZ	  with	  just	  0.4	  mM	  IPTG.	  The	  induction	  increased	  the	  level	  of	  expression	   in	   the	   supernatant	   (Fig.4.6).	   The	   protein	   was	   soluble.	   Then	   we	  proceeded	  with	  the	  same	  purification	  strategy	  adopted	  before,	  expressing	  4	  L	  of	  protein,	   lysing	   the	   cells	   by	   sonication	   and	   loading	   the	   lysed	   cells	   on	   a	   nickel	  column.	   After	   chromatography	   the	   fractions	   of	   washing	   and	   of	   elution	   steps	  obtained	  from	  the	  column	  were	  loaded	  on	  a	  SDS	  gel	  at	  12%	  (Appendix,	  Fig	  A.4).	  We	   collected	  and	  dialyzed	  not	  only	   the	   fractions	   coming	   from	   the	   elution	  with	  255	  mM	  imidazole	  but	  also	  the	  fraction	  coming	  from	  the	  washing	  step	  with	  65m	  M	   imidazole.	   The	   fluorescence	   in	   the	   fractions	   collected	  was	   remarkable.	  After	  dialysis	  and	  concentration,	  the	  protein	  was	  stored	  in	  15	  %	  glycerol	  at	  -­‐80°	  C.	  	  At	  the	   end	   of	   the	   purification	   the	   absorbance	   of	   the	   protein	   at	   280	   nm	   was	  measured(Fig.4.7).	   The	   concentration	   of	   the	   protein	  was	   calculated,	   exploiting	  the	   absorbance	   at	   517	   nm	   that	   corresponded	   to	   the	   excitation	   wavelength	   of	  YPet.	   The	   extinction	   coefficient,	   used	   for	   calculating	   the	   concentration,	   was	  relative	  to	  the	  excitation	  wavelength	  of	  YPet	  (517nm)	  and	  is	  of	  104,000	  M-­‐1cm-­‐1.	  Also	   in	   this	   case	  we	  exploited	   the	  Beer’s	   law,	   and	   the	   concentration	   calculated	  was	   10.4	   µM.	   The	   quality	   of	   the	   purification	   was	   confirmed	   by	   fluorescence	  spectroscopy,	  acquiring	  excitation	  and	  emission	  scan	  of	  YFP-­‐FtsZ.	  The	  YFP/YPet	  has	  an	  excitation	  peak	  at	  517	  nm	  and	  an	  emission	  peak	  at	  530	  nm.	  These	  peaks	  were	  confirmed	  by	  the	   fluorescence	  spectra	  (Fig.	  4.8).	  As	  mentioned	  before	  we	  dialyzed	   the	   imidazole	   and	   stored	   the	  protein	   collected	   from	   the	  washing	   step	  with	   65	   mM	   imidazole.	   The	   UV	   and	   the	   fluorescence	   spectrum	   are	   reported	  respectively	   in	   Fig.	   4.9	   and	   4.10.	   The	   final	   concentration	   calculated	   for	   the	  protein	  was	  of	  36.3	  µM.	  	  	  
	  	   72	  
	  
Fig	  4.6:	  Test	  of	  solubility	  for	  YFP-­‐FtsZ,	  the	  protein	  is	  soluble.	  Lane	  A	  is	  the	  protein	  ladder	  from	  10-­‐250	  kDa	  (NEB).	  YFP-­‐FtsZ	  is	  over-­‐expressed	  in	  the	  supernatant	  by	  induction	  with	  0.4	  mM	  IPTG	  (lane	  D)	  and	  in	  the	  pellet	  (lane	  E).	  In	  absence	  of	  IPTG	  the	  protein	  is	  more	  expressed	  in	  the	  pellet	  (lane	  C)	  than	  in	  the	  supernatant	  (lane	  B).	  	  	  	  	  	  	  	  
	  	   73	  
	  
Fig.4.7	   :	  UV	   spectrum	   	   of	   YFP-­‐FtsZ	   eluted	   from	   the	   column	  with	   255	  mM	  of	   imidazole.	   Two	  peaks	   were	   detected.	   The	   first	   peak	   is	   at	   280	   nm	   and	   corresponds	   to	   the	   absorbance	   of	   the	  	  aromatic	  residues	  of	  	  the	  protein.	  The	  second	  peak	  at	  517	  nm,	  corresponds	  to	  the	  chromophore	  excitation	  wavelength	  of	   the	  YFP	  (YPet)	  present	   in	   the	  protein.	  The	  amount	  of	   the	  protein	  was	  calculated	  exploiting	  the	  extinction	  coefficient	  and	  the	  absorbance	  at	  515	  nm	  of	  the	  YFP/YPet.	  	  
	  
Fig	   4.8:	   	   Excitation	   and	   emission	   scan	   of	   YFP-­‐FtsZ,	   eluted	   from	   the	   column	   with	   255mM	  imidazole.	  YFP-­‐FtsZ	  has	  an	  excitation	  peak	  at	  515	  (red	  line)	  nm	  and	  an	  emission	  peak	  at	  530	  nm	  (blue	  line).	  The	  purification	  leaded	  to	  the	  right	  protein.	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  Fig	  4.9:	   	  UV	  spectrum	  of	  YFP-­‐FtsZ	  	  after	  the	  washing	  step	  with	  65	  mM	  of	  imidazole.	  Two	  peaks	  were	  detected.	  The	   first	  peak	   is	  detected	  at	  280	  nm	  and	  corresponds	   to	   the	  absorbance	  of	   the	  	  aromatic	  residues	  of	  the	  protein.	  The	  second	  peak	  at	  517	  nm,	  corresponds	  to	  the	  chromophore.	  The	  amount	  of	  the	  protein	  was	  calculated	  exploiting	  the	  extinction	  coefficient	  and	  the	  absorbance	  	  	  at	  515	  nm	  of	  the	  YFP/YPet.	  	  	  
	  
Fig.	  4.10:	  Excitation	  and	  emission	  scan	  of	  YFP-­‐FtsZ,	  	  after	  washing	  with	  65	  mM	  imidazole.	  YFP-­‐FtsZ	  has	  an	  excitation	  peak	  at	  517	  (red	  line)	  nm	  and	  an	  emission	  peak	  at	  530	  nm	  (blue	  line)	  The	  purification	  leaded	  to	  the	  right	  protein.	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FtsZ-­‐YFP-­‐MinD	   and	   YFP-­‐FtsZ	   behave	   as	   soluble	   proteins	   and	   so	   can	   be	  	  purified	  under	  native	  conditions.	  The	  amount	  of	  proteins	  obtained	  was	  sufficient	  for	   the	   development	   of	   later	   experiments	   of	   encapsulation	   in	   w/o	   emulsions.	  Two	   possible	   fluorescent	   version	   of	   FtsZ	   for	   the	   construction	   of	   our	   minimal	  division	  machinery	   system	  were	   purified	   but	   	  were	   not	   sufficient	   to	   reach	   the	  goal	  of	  building	  a	  minimal	  system	  made	  of	  FtsZ	  and	  FtsA.	  So	  we	  proceeded	  with	  the	  expression	  in	  vivo	  and	  the	  purification	  of	  FtsA	  constructs.	  	  	  4.2.2	  In	  vivo	  expression	  and	  purification	  of	  FtsA	  constructs.	  	   Prior	   to	   the	  design	  of	   the	   fluorescent	  constructs	   for	  FtsA	  and	   test	  of	   the	  solubilities,	  we	   investigated	   the	   behavior	   of	   FtsA	   in	   the	   absence	   of	   fluorescent	  tags.	  We	  tested	  the	  solubility	  of	  FtsA	  subcloned	  in	  a	  pET-­‐TEV	  (Fig	  4.11)	  vector.	  Different	   concentrations	   of	   IPTG	   were	   tested.	   In	   general,	   FtsA	   was	   more	  expressed	  in	  the	  pellet	  than	  in	  the	  supernatant.	  This	  result	  was	  expected	  because	  of	  the	  hydrophobic	  nature	  of	  FtsA.	  	  	   	  
Fig	  4.11:	  FtsA	  is	  not	  a	  soluble	  protein.	  FtsA	  has	  a	  MW	  of	  40.2	  kDa.	  Lane	  B	  is	  the	  protein	  ladder	   from	   10-­‐250	   kDa	   (NEB).	   In	   lane	   A,	  correspondent	   to	   the	   expression	   of	   the	  protein	  before	  the	  induction,	  is	  not	  possible	  to	   detect	   the	   protein	   of	   interest.	   FtsA,	  instead,	  is	  over-­‐expressed	  in	  the	  pellet	  (lane	  C)	  both	  with	  0.1	  mM	  IPTG	  and	  both	  with	  0.4	  mM	  IPTG	  (lane	  F).	  In	  the	  supernatant	  is	  low	  expressed	   both	   with	   0.1	   mM	   and	   0.4	   mM	  IPTG	  (lane	  C	  and	  lane	  E)	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  FtsA	  without	  a	   fluorescent	   tag	   is	  mostly	  present	   in	   the	  pellet.	  Therefore	  we	  designed,	  sucbcloned	  and	  expressed	  in	  E.	  coli	  BL21	  (DE3)	  Rosetta,	  CFP-­‐FtsA	  and	   CFP-­‐R286W	   FtsA.	   We	   tested	   the	   solubility	   of	   CFP-­‐FtsA	   in	   order	   to	  understand	  the	  purification	  strategy	  to	  set	  up	  for	  later	  purification	  (Fig.4.12).	  Unfortunately	  there	  is	  no	  sample	  of	  control	   in	  the	  gel	  shown	  in	  figure	  4.13,	  but	  clearly	  the	  protein	  is	  mostly	  expressed	  in	  the	  pellet,	  after	  induction	  with	  0.1	  mM	  IPTG	  (lane	  C)	  and	  after	  induction	  with	  0.4	  mM	  IPTG	  (lane	  E).	  The	  production	  in	  the	  supernatant	  was	   increased	  by	   induction	  with	  0.1	  and	  0.4	  mM	  IPTG	  (lane	  B	  and	  D).	  In	  conclusion,	  CFP-­‐FtsA	  is	  not	  a	  soluble	  protein,	  for	  this	  reason	  we	  set-­‐up	  a	  purification	  platform	  under	  native	  conditions,	   adding	  a	  mild	  detergent	   in	   the	  buffer	  and	  we	  performed	  a	  purification	  under	  denaturating	  conditions	  exploiting	  as	  denaturating	  agent	  	  urea.	  	  	  
	  
Fig	  4.12:	  CFP-­‐FtsA	  is	  not	  a	  soluble	  protein.	  CFP-­‐FtsA	  has	  a	  MW=75.7kDa.	  The	  protein	  is	  mostly	  expressed	  in	  the	  pellet	  after	  induction	  with	  0.1mM	  IPTG	  (lane	  C)	  and	  after	  induction	  with	  0.4	  mM	  IPTG	  (lane	  E).	  The	  protein	  is	  low	  expressed	  in	  the	  supernatant	  both	  with	  0.1	  mM	  IPTG	  (lane	  B)	  and	  both	  with	  0.4	  mM	  IPTG	  (lane	  D).	  Lane	  B	  is	  the	  protein	  ladder	  from	  10-­‐250	  kDa	  (NEB).	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Because	  of	  this	  behavior	  we	  evaluated	  two	  possible	  strategies	  for	  the	  expression	  and	  purification	  of	  CFP-­‐FtsA.	  The	  first	  strategy	  forecasts	  the	  possibility	  of	  purifying	  CFP-­‐FtsA	  under	  native	  conditions	  exploiting	  a	  mild	  detergent	  during	  the	  process	  of	  lysis.	  The	  second	  strategy	  instead	  forecasts	  the	  possibility	  of	  purify	  CFP-­‐	  FtsA	  under	  denaturating	  conditions.	  4	  L	  of	  expression	  were	  performed.	  The	  cultures	  were	  induced	  with	  0.1	  mM	  IPTG	  after	  the	  OD600	  reached	  the	  value	  of	  0.6.	  The	  over	  expression	  was	  performed	  at	  30°C	  for	  4	  h.	  Then	  the	  cells	  were	  lysed	  in	  50	  mL	  of	  50	  mM	  TrisHCl,	  300	  mM	  NaCl,	  10	  mM	  MgCl2	  ,pH	  8.0	  and	  1%	  of	  IGEPAL	  (Octylphenyl-­‐polyethylene	  glycol;	  CA-­‐630,	  Sigma-­‐Aldrich).	  The	  IGEPAL	  is	  classified	  as	  a	  non-­‐ionic,	  non	  denaturing	  detergent	  otherwise	  known	  also	  as	  a	  mild	  detergent.	  This	  kind	  of	  detergents	  disrupt	  lipid-­‐lipid	  interaction	  and	  lipid	  –protein	  interactions	  rather	  than	  protein-­‐protein	  interactions	  58.	  These	  features	  allows	  to	  the	  	  non	  soluble	  protein	  to	  be	  solubilized	  in	  the	  non	  ionic	  detergent	  without	  affecting	  the	  protein’s	  structural	  features,	  such	  that	  can	  be	  isolated	  in	  its	  biologically	  active	  form	  59.	  The	  cells	  lysed	  in	  the	  buffer	  mentioned	  before,	  were	  sonicated	  and	  then	  loaded	  on	  a	  Ni/Nta2+	  column.	  The	  fractions	  eluted	  from	  the	  column	  were	  loaded	  on	  a	  12%	  SDS	  gel	  (Fig.4.13).	  It	  is	  possible	  to	  see	  the	  band	  corrispondent	  to	  CFP-­‐FtsA	  (MW=75.7	  kDa).	  The	  protein	  is	  present	  in	  the	  fractions	  from	  lane	  E	  to	  lane	  O	  in	  figure	  4.13,	  deriving	  from	  the	  elution	  with	  255mM	  imidazole.	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Fig	   4.13:	   Purification	   of	   CFP-­‐FtsA	   (MW=75.7	   kDa)	   under	   native	   conditions	   exploiting	   1%	   of	  IGEPAL.	  Lane	  A	  is	  the	  flow	  through,	  lane	  C	  is	  the	  protein	  ladder	  from	  10-­‐250	  kDa	  (NEB),	  lane	  B	  is	  the	   first	  washing	   of	   the	   column	  with	   binding	   buffer,	   containing	   5	  mM	   imidazole;	   lane	  D	   is	   the	  washing	   step	  with	  20	  mM	  of	   imidazole	   and	   lane	  E	   is	   the	  washing	   step	  with	  65	  mM	   imidazole.	  Lane	  from	  F	  to	  O	  are	  the	  lanes	  correspondent	  to	  the	  protein	  eluted	  with	  255	  mM	  imidazole.	  	  	   Although	  the	  gel	  shows	  that	  the	  protein	  eluted	  correspond	  to	  the	  MW	  of	  CFP-­‐FtsA	   (75.7	   kDa),	   the	   detection	   by	   UV	   spectroscopy	   and	   fluorescence	  spectroscopy	   of	   the	   protein	   dyalized	   and	   concentrated,	   did	   not	   show	   	   peaks	  characteristic	   of	   CFP.	   For	   this	   reason	   we	   decided	   to	   purify	   CFP-­‐FtsA	   under	  denaturing	  conditions	  (Fig.4.13).	  The	  urea	  was	  added	  just	  in	  the	  lysis	  buffer,	  the	  buffer	   instead	   used	   for	   the	   affinity	   chromatography	   were	   not	   provided	   with	  	  urea.	   	  The	  urea	  denaturates	  the	  protein,	  so	  the	  protein	  loose	  the	  secondary	  and	  tertiary	  structure	  and	  consequentially	  also	  the	  functionality.	  The	  choice	  of	  using	  the	   urea,	   as	   denaturant	   agent,	  was	   dictated	   by	   the	   fact	   that	   the	   urea	   does	   not	  interfere	  with	  SDS,	  so	  the	  fractions	  collected	  from	  the	  column	  could	  be	  directly	  loaded	   on	   the	   gel	   without	   any	   further	   step	   of	   clean-­‐up,	   ie.	   the	   guanidine	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hydrochloride	  (GuHCl)	  interfere	  with	  SDS,	  so	  eventually	  the	  sample	  need	  to	  be	  	  precipitated	  with	  Trichloroacetic	  acid	  (TCA	  precipitation).The	  protein	  denatured	  does	  not	   have	   functionality	   so	   is	   necessary	   after	   the	  purification	   to	   re-­‐fold	   the	  protein	  and	  the	  urea	  needs	  to	  be	  diluted.	  The	  8	  M	  urea	  present	  in	  the	  fractions	  collected	   from	   the	   column	   from	   the	   elution	   step,	   approximately	   40	   mL,	   	   was	  diluted	   with	   50	   mL	   of	   	   a	   buffer	   10mM	   BME,	   0.1	   mM	   CHAPS	  ([(3cholamidopropyl)dimethylammonio]-­‐1	  –propanesulfonate]),	  50	  mM	  TrisHCl,	  50	  mM	   	  NaCl	   pH	  7.4.	   The	  buffer	  was	   added	  dropwise,	   o/n	   from	  a	   column	   in	   a	  beaker	  containing	  the	  protein.	  After	  dialysis	  and	  concentration,	  an	  UV	  spectrum	  and	  emission	   and	  excitation	   scans	  were	   acquired.	   In	   the	  UV	   spectrum	  was	  not	  possible	   to	   see	   the	   excitation	   peak	   correspondent	   to	   the	   CyPet	   present	   in	   the	  protein	   (CyPet	   has	   an	   Ex=435	   nm	   and	   an	   Em=477	   nm).	   The	   excitation	   and	  emission	   scan,	   instead,	   were	   not	   correspondent	   to	   the	   expected	   peaks	   of	   the	  protein.	  	  
 	   	  
Fig.	   4.13:	  CFP-­‐FtsA	   is	  purified	  under	  denaturing	   conditions,	   using	   8	   M	  urea.Lane	   G	   is	   the	   protein	   ladder	  from	   10-­‐250	   kDa	   (NEB).	   The	  fractions	   from	   lane	   H	   to	   lane	   M	   are	  the	   fraction	   eluted	   with	   255	   mM	  imidazole.	   The	   fraction	   in	   the	   lane	   E	  and	   lane	  F	  are	   the	   fractions	   from	  the	  washing	   step	   respectively	   with	   20	  mM	   imidazole	  and	  65	  mM	   imidazole,	  respectively	   Lane	   C	   and	   lane	   D	   are	  correspondent	   to	   the	   fraction	   after	  the	   washing	   with	   just	   5	   mM	  imidazole.	  Lane	  B	  	  is	  the	  flow	  through.	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   We	  tried	  to	  follow	  the	  same	  protocol	  also	  for	  the	  purification	  of	  CFP-­‐FtsA	  R286W	  but	  the	  difficulties	  encountered	  were	  the	  same.	  Probably	  the	  fact	  that	  we	  were	  never	  be	  able	  to	  see	  the	  proper	  peaks	  of	  excitation	  and	  emission	  of	  CyPet,	  is	  a	  because	  the	  protein	  does	  not	  refold	  in	  the	  proper	  way.	  The	  difficult,	  to	  obtain	  a	  functional	   fluorescent	   version	   for	   FtsA	   pushed	   us	   to	   synthesize	   a	   minimal	  division	   machinery	   system	   directly	   inside	   w/o	   emulsion	   and	   phospholipids	  vescicles.	  Howewer	  we	   tried	   to	   encapsulate	   in	  w/o	   emulsions	   the	  protein	   that	  we	  were	  able	  to	  purify	  and	  observed	  some	  interesting	  phenomena.	  	  	  	  4.2.3	  Encapsulation	  of	  FtsZ	  and	  FtsA	  constructs	  in	  w/o	  emulsions.	  	  	   After	   the	   purification	   of	   FtsZ-­‐YFP-­‐MinD,	   YFP-­‐FtsZ	   and	   FtsA	   were	  encapsulated	  in	  w/	  o	  emulsions	  and	  visualized	  by	  fluorescence	  microscopy.	  The	  purpose	   of	   the	   encapsulation	   was	   to	   investigate	   the	   phenomenon	   of	  polymerization	  of	  FtsZ	  in	  the	  presence	  of	  guanosine	  triphosphate	  (GTP)60,61.The	  formation	   of	   bundles	   of	   polymers	   in	   presence	   of	   CaCl262,63,	   and	   the	   possible	  interactions	   between	   FtsZ	   and	   FtsA.	   FtsZ	   in	   presence	   of	   GTP	   is	   able	   to	  polymerize	  and	  in	  certain	  buffer	  compositions,	  the	  effect	  of	  polymerization	  was	  also	  increased60.	  The	  buffers	  used	  in	  our	  experiments	  were	  HEK	  100,	  composed	  by	   50	  mM	  HEPES,	   100mM	  potassium	  acetate	   (KAc)	   pH	  7.7,	   2.5	  mM	  EDTA	   and	  HMK	  composed	  by	  50	  mM	  HEPES,	  pH	  7.7,	  100	  mM	  KAc	  and	  5	  mM	  MgCl2.	  In	  each	  buffer	   there	   is	   always	   the	   presence	   of	   KAc.	   The	   potassium	  plays	   an	   important	  role	  in	  the	  assembly	  of	  FtsZ	  subunits	  during	  polymerization.	  In	  fact	  in	  E.	  coli	  cells	  the	  physiological	  concentration	  of	  KAc	  is	  of	  350mM.	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In	  figure	  4.14	  are	  reported	  images	  of	  w/o	  emulsions	  encapsulating	  FtsZ-­‐YFP-­‐MinD	  and	  YFP-­‐FtsZ.	  The	  emulsions	  were	  produced	  in	  the	  way	  described	  in	  the	   previous	   sections.	   The	   protein	   represent	   the	   aqueous	   phase	   of	   the	   w/o	  emulsions.	   In	   general	   the	   concentration	   of	   the	   protein,	   of	   the	   GTP	   and	   CaCl2	  	  	  adopted	   in	   our	   experiments	   were	   alike	   to	   in	   a	   total	   volume	   of	   50 µL.	   The	  emulsions	  once	  produced,	  were	  visualized	  by	  fluorescence	  microscopy.	  	  	  5	   µM	   FtsZ-­‐YFP-­‐MinD	   was	   encapsulated	   in	   w/o	   emulsions	   and	   forms	  aggregates	  (panel	  A).	  The	  aggregates	  were	  more	  spread	  in	  the	  emulsions	  in	  	  the	  presence	  of	  2	  mM	  GTP	  (panel	  B).	  The	  buffer	  used	  was	  the	  HEK	  buffer.	  5	  µM	  YFP-­‐FtsZ	  (Fig	  4.15,	  panel	  C	  and	  panel	  D)	  was	  encapsulated	  in	  emulsion,	  in	  HEK	  buffer.	  In	  absence	  of	  GTP	  was	  rare	  to	  observe	  aggregates	  (Fig	  4.15,	  panel	  C)	  in	  presence,	  instead,	  of	  2	  mM	  GTP	  (Fig	  4.15,	  panel	  D),	  the	  effect	  of	  aggregation	  is	  spread	  in	  the	  volume	  of	  emulsion.	  Similarly	  5	  µM	  YFP-­‐FtsZ	  alone	   in	  HMK	  buffer	   formed	  rare	  polymers	  in	  absence	  of	  GTP	  (Fig	  4.15,	  panel	  E).	  5	  µM	  YFP-­‐FtsZ	  plus	  2	  mM	  GTP	  in	  HMK	   buffer	   formed	   evident	   aggregates.	   The	   term	   aggregation	   is	   used	   here	  instead	   of	   polymerization,	   because	   just	   the	   electron	   microscopy	   is	   needed	   in	  order	  to	  understand	  if	  proto	  filaments	  are	  formed	  or	  not64-­‐66.	  	   Finally	   in	   figure	   4.15	   is	   reported	   an	   image	   obtained	   encapsulating	   YFP-­‐FtsZ	   in	   w/o	   emulsions	   with	   the	   addition	   of	   100	   mM	   CaCl2.	   It	   is	   possible	   to	  observe	   a	   strong	   effect	   of	   aggregation,	   perhaphs	   due	   to	   the	   bundling	   of	   the	  polymers	  of	  FtsZ.	  Finally	  we	  tried	  also	  to	  encapsulate	  FtsA	  with	  YFP-­‐FtsZ	  inside	  w/o	   emulsions	   with	   a	   concentration	   of	   1	   µM	   but	   there	   were	   not	   significative	  differences	  between	  samples.	  	  	  Although	  we	  were	  able	  to	  see	  changing	  in	  the	  morphology	  of	  FtsZ	  with	  the	  addition	   of	   2	  mM	  GTP	   and	   10	  mM	   CaCl2,	   this	   artificial	  model	   is	   not	   satisfying	  because	   it	   does	   not	   permit	   us	   to	   see	   interactions	   between	   FtsZ	   and	   FtsA,	   and	  does	  not	  mediate	  division.	  
	  	   82	  
	  
Fig	  4.14:	  Fluorescence	  microscopy	  images	  of	  the	  encapsulation	  of	  FtsZ-­‐YFP-­‐Mind	  and	  YFP-­‐FtsZ	  inside	  w/	  o	  emulsions.	  FtsZ-­‐YFP-­‐MinD	  in	  HEK	  buffer	  is	  encapsulated	  in	  the	  emulsions	  and	  form	  rare	  aggregates	  (panel	  A).	  With	  the	  addition	  of	  2	  mM	  	  	  GTP	  we	  can	  notice	  a	  more	  spread	  effect	  of	  polymerization	  (panel	  B).	  YFP-­‐FtsZ	  in	  buffer	  HEK	  forms	  rare	  polymers	  (panel	  C).	  In	  presence	  of	  2	  mM	   GTP	   YFP-­‐FtsZ	   aggregates	   more	   (panel	   D).	   In	   buffer	   HMK	   the	   formation	   of	   polymers	   in	  presence	  of	  2	  mM	  GTP	  is	  increased	  (panel	  F)	  compared	  with	  the	  sample	  without	  GTP	  (panel	  E)	  and	  compared	  with	  the	  other	  conditions	  described	  before.	   YPet	  fluorescence	  is	  detected	  with	  a	  FITC	  filter	  and	  is	  false	  colored	  in	  green.	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Fig	  4.	  15:	  Bundling	  of	  YFP-­‐FtsZ	  effect	  generated	  by	  the	  addition	  of	  10	  mM	  CaCl2	  in	  aqueous	  phase	  of	  the	  emulsion	  The	  protein	  encapsulated	  appears	  more	  aggregated	  than	  in	  the	  presence	  of	  just	  GTP.	  The	  YPet	  fluorescence	  is	  visualized	  by	  fluorescence	  microscopy	  detected	  with	  a	  FITC	  filter	  and	  false	  colored	  in	  green.	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4.3	  Materials	  and	  Methods	  	  4.3.1Bacterial	  strains	  and	  plasmids.	  	  FtsZ	  (pET-­‐TEV),	  FtsA	  (pET-­‐TEV),	  FtsZ-­‐YFP-­‐MinD	  (pET21b),	  YFP-­‐FtsZ	  (pET21b)	  	  CFP-­‐FtsA	  and	  CFP-­‐	  R286W	  FtsA	  (pET21b)	  were	  expressed	  in	  E	  .	  coli	  BL21	  (DE3)	  Rosetta	  (F-­‐	  ompT	  hsdSB(RB-­‐	  mB-­‐)	  gal	  dcm	  λ(DE3	  [lacI	  lacUV5-­‐T7	  gene	  1	  ind1	  sam7nin5])pLysSRARE(CamR).	  This	  strain	  contains	  the	  pLysSRARE	  plasmid,	  which	  is	  similar	  to	  pLysS	  but	  also	  contains	  tRNA	  genes	  for	  codons	  that	  are	  rarely	  used	  in	  E.	  coli,	  ie.	  tRNA	  genes	  as	  argU	  (AGA,	  AGG),	  ileX	  (AUA),	  glyT	  (GGA),	  leu	  W(CUA).	  Rosetta	  cells	  are	  chloramphenicol	  resistant	  and	  have	  DE3	  λ	  prophage	  carrying	  the	  T7	  RNA	  polymerase	  gene	  and	  lacIq.	  	  	  4.3.2	  Test	  of	  protein	  solubility.	  	  
E.	  coli	  	  BL21(DE3)cells	  were	  transformed	  as	  described	  above	  with	  plasmids	  coding	  for	  FtsZ,	  FtsA,	  FtsZ-­‐YFP-­‐MinD,	  YFP-­‐FtsZ	  and	  CFP-­‐FtsA.	  10	  mL	  of	  LB	  supplemented	  with	  100	  μg/ml	  ampicillin,	  were	  	  inoculated	  with	  100	  μL	  of	  E.	  coli	  BL21(DE3)	  Rosetta	  from	  an	  overnight	  culture	  and	  grown	  at	  37°C,	  220	  rpm.	  	  Once	  the	  culture	  reached	  an	  OD600	  of	  0.6,	  a	  pre-­‐induction	  sample	  of	  500	  μL	  was	  collected	  (in	  the	  major	  part	  of	  the	  cases)	  centrifuged	  at	  13000	  rpm	  for	  10	  min,	  and	  stored	  at	  -­‐20	  °C.	  	  Then	  	  the	  cultures	  were	  induced	  with	  0.1	  mM	  or	  0.4	  mM	  	  IPTG.	  The	  post	  induction	  incubation	  of	  the	  cells	  was	  for	  4	  h	  and	  in	  the	  case	  of	  the	  overexpression	  of	  CFP-­‐FtsA	  at	  30°C.	  In	  order	  to	  separate	  the	  soluble	  and	  insoluble	  protein	  fractions	  to	  load	  on	  the	  SDS-­‐PAGE	  gel,	  the	  cellwere	  lysed.	  Cells	  were	  harvested	  by	  centrifugation	  at	  5000	  rpm	  at	  4°C	  	  for	  10	  min	  and	  resuspended	  in	  500	  μL	  of	  50	  mM	  Tris-­‐HCl,	  pH	  7.4.	  Cells	  were	  sonicated	  1	  min	  with	  a	  cycle	  time	  of	  15	  s	  on	  and	  30	  s	  off	  to	  avoid	  excessive	  heating	  and	  formation	  of	  foam.	  After	  centrifugation	  at	  13000	  rpm	  at	  4°C	  for	  20	  min	  the	  supernatant	  was	  collected	  in	  new	  eppendorf	  tubes	  and	  stored	  at	  -­‐20	  °C	  (soluble	  fraction).	  The	  pellet	  was	  stored	  at	  -­‐20	  °C	  (insoluble	  fraction).	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  4.	  3.3	  SDS-­‐PAGE	  	   As	  soon	  as	  5	  mL	  volume	  resolving	  gel	  was	  moved	  into	  the	  gel	  chamber,	  it	  was	  covered	  with2	  mM	  of	  n-­‐butanol	  to	  exclude	  O2	  and	  ensure	  a	  gel	  flat	  interface.	  After	  15	  min	  polymerization,	  n-­‐butanol	  was	  removed	  and	  the	  stacking	  gel	  was	  poured	  with	  a	  comb	  inserted	  to	  form	  the	  wells	  and	  define	  the	  lanes	  and	  allowed	  to	  polymerize	  for	  10	  min.	  The	  samples	  that	  were	  loaded	  onto	  the	  SDS-­‐PAGE	  gel	  were	  prepared	  as	  follows:	  the	  pellet	  (insoluble	  fraction)	  was	  resuspended	  in	  200	  μL	  of	  Tris-­‐HCl,	  pH	  7.0	  and	  200	  μL	  of	  SDS	  loading	  buffer	  (1	  M	  Tris-­‐Cl	  pH	  6.8	  2.4	  mL,	  20%	  SDS,	  Glycerol	  (100%)	  3	  mL,	  B-­‐mercaptoethanol	  1.6	  mL	  Bromophenol	  blue	  0.006g	  10	  mL	  (store	  -­‐20	  deg	  C)	  10	  μL	  aliquot	  from	  the	  supernatant	  (soluble	  fraction)	  was	  mixed	  with	  10	  μL	  of	  SDS	  loading	  buffer;	  the	  pre-­‐induction	  pellet	  	  was	  resuspended	  in	  50	  μL	  of	  SDS	  loading	  buffer.	  All	  three	  samples	  were	  heated	  for	  5	  min	  at	  94	  °C.	  While	  the	  soluble	  fraction	  was	  ready	  to	  be	  loaded,	  the	  insoluble	  fraction	  and	  the	  pre	  induction	  sample	  were	  centrifuged.	  20	  μL	  from	  each	  sample	  were	  loaded	  on	  	  SDS-­‐PAGE	  gel	  lanes.	  The	  ladder	  a	  Protein	  Ladder	  (P7703S,	  NEB)	  and	  the	  volume	  used	  was	  of	  5µL.The	  gel	  was	  run	  at	  140	  V,	  400	  mA,	  for	  2	  h.	  Staining	  was	  performed	  with	  Coomassie	  Staining	  solution(	  	  50%	  MeOH	  ,10%	  Acetic	  Acid	  ,0.05%	  Brilliant	  Blue	  R-­‐25)	  	  and	  was	  allowed	  to	  continue	  overnight	  with	  mild	  shaking.	  Destaining	  was	  performed	  for	  3	  h	  with	  de-­‐staining	  solution(50%	  MeOH	  ,40%	  milli-­‐Q	  water	  ,10%	  Acetic	  Acid)	  with	  mild	  shaking.	  The	  samples	  of	  the	  different	  fraction	  coming	  from	  the	  column	  were	  heated	  in	  loading	  buffer	  at	  94	  °C	  and	  loaded	  on	  a	  10%	  SDS	  gel.	  
 
 4.3.4	  	  Affinity	  chromatography	  protein	  purification.	  
 Cells	  were	  harvested	  by	  centrifugation	  at	  4000	  X	  g	  for	  20	  min	  at	  4	  °C	  and	  the	  supernatant	  discarded.	  Pellets	  were	  resuspended	  in	  ca.	  50	  mL	  of	  Binding	  Buffer	  (50	  mM	  NaH2PO4,	  300	  mM	  NaCl,	  5	  mM	  imidazole,	  pH	  7.4	  ).	  For	  the	  resupension	  of	  the	  pellet	  of	  CFP-­‐FtsA	  we	  used	  50	  mM	  TrisHCl,	  300	  mM	  NaCl,	  10	  mM	  MgCl2,	  pH	  8.0	  and	  1%	  IGEPAL	  (Octylphenyl-­‐polyethylene	  glycol;	  CA-­‐630,	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Sigma-­‐Aldrich).	  The	  lysis	  buffer	  for	  the	  purification	  under	  denaturant	  conditions	  was	  made	  of	  8	  M	  urea,	  300	  mM	  	  NaCl	  and	  50	  mM	  NaH2PO4	  pH	  8.In	  general	  to	  the	  pellets	  resuspended	  were	  added	  	  0.4	  mg/mL	  Lysozime,	  1mM	  phenyl	  methane	  sulfonyl	  fluoride(PMSF)	  and	  0.1%	  BME.	  The	  lysis	  was	  performed	  through	  sonication	  with	  a	  cycle	  time	  of	  15	  s	  on	  and	  30	  second	  off	  for	  2	  min	  of	  sonication	  time	  keeping	  falcons	  in	  ice.	  Cell	  lysate	  was	  centrifuged	  at	  9000	  X	  g	  for	  30	  min	  at	  4	  °C	  and	  the	  crude	  extract	  (supernatant)	  was	  diluted	  5	  fold	  with	  Binding	  Buffer.	  Ni/Nta	  agarose	  resin	  from	  Qiagen	  stock	  solution	  2	  g/mL	  was	  loaded	  into	  a	  2.5x10	  cm	  gravity-­‐flow	  chromatography	  column	  until	  a	  final	  volume	  of	  5	  mL	  packed	  in	  the	  bottom.	  The	  column	  was	  washed	  with	  3	  column	  volumes	  of	  water.	  Then	  the	  resin	  was	  charged	  with	  100	  mM	  NiSO4	  and	  washed	  for	  3	  column	  volumes	  with	  Binding	  Buffer(50	  mM	  NaH2PO4,	  300	  mM	  NaCl,	  5	  mM	  imidazole,	  pH	  7.4	  ).The	  diluted	  crude	  extract	  was	  loaded	  and	  allowed	  to	  go	  through	  the	  resin	  in	  order	  to	  have	  1	  mL	  per	  min	  flowed	  through.	  A	  sample	  of	  flow	  through	  was	  collected	  and	  stored	  at	  4	  °C	  to	  load	  later	  on	  the	  SDS	  PAGE	  gel.	  The	  column	  was	  washed	  with	  3	  column	  volumes	  of	  Binding	  Buffer	  +	  20	  mM	  imidazole	  and	  3	  column	  volumes	  of	  Binding	  Buffer	  plus	  60	  mM	  imidazole	  and	  the	  fractions	  of	  washing	  were	  collected	  in	  50	  mL	  falcon	  tubes.	  Elution	  was	  made	  with	  Elution	  Buffer	  made	  by	  Binding	  Buffer	  plus	  250	  mM	  imidazole	  and	  8	  fractions	  of	  4-­‐5	  mL	  elution	  were	  collected.	  Regenerating	  the	  column	  required	  washes	  with	  3	  column	  volumes	  of	  water	  and	  1-­‐2	  column	  volume	  of	  stripping	  buffer	  (100	  mM	  EDTA,	  pH	  8).	  	  	  4.3.5	  Dialysis.	  	   The	  fractions	  of	  FtsZ-­‐YFP-­‐MinD	  and	  YFP-­‐FtsZ	  	  eluted	  from	  the	  column,	  were	  collected	  in	  a	  Snake	  Skin	  Dialysis	  membrane	  (Thermoscientific)	  with	  7	  K	  molecular	  weight	  cut	  off	  (MWCO)	  and	  	  dialyzed	  f	  in	  2	  L	  of	  	  50	  mM	  TrisHCl	  ,	  50	  mM	  NaCl,	  1	  mM	  BME.	  For	  the	  dialysis	  of	  CFP-­‐FtsA	  the	  buffer	  composition	  was	  slightly	  different	  (50	  mM	  TrisHCl	  ,	  50	  mM	  NaCl,	  1	  mM	  BME,	  0.1	  mM	  CHAPS).	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4.3.6	  Protein	  concentration	  and	  storage.	  	   The	  proteins	  from	  a	  volume	  varying	  between	  40	  mL-­‐100	  mL	  were	  concentrated	  with	  a	  stirred	  cell	  concentrator	  of	  different	  sizes,	  depending	  from	  the	  volume	  to	  concentrate.	  The	  membrane	  used	  was	  an	  Amicon	  membrane	  of	  10K	  MWCO.	  The	  protein	  were	  stored	  at	  -­‐	  80°C	  in	  5	  %	  glycerol.	  	  	  4.3.7	  Instrumentation	  	  The	  sonicator	  used	  is	  a	  MISONIX	  S-­‐4000.	  The	  program	  used	  for	  the	  extraction	  of	  the	  proteins	  from	  the	  E	  .coli	  cells	  	  exploits	  an	  amplitude	  of	  70	  and	  is	  provided	  with	  a	  tip.	  The	  UV-­‐Vis	  used,	  is	  an	  Agilent	  8453	  spectrophotometer.	  The	  absorbance	  was	  measured,	  using	  60	  µL	  of	  sample	  and	  setting	  a	  range	  of	  absorbance	  from	  250	  nm	  to	  70	  nm.	  Excitation	  and	  emission	  scan	  were	  acquired	  using	  a	  Photon	  Technology	  International	  (PTI)	  Quanta	  Master	  40	  UV	  VIS	  spectrofluorometer	  equipped	  with	  two	  detectors	  (T-­‐format).	  The	  emission	  scans	  were	  acquired	  starting	  from	  the	  excitation	  wavelength	  +	  5	  nm	  to	  the	  emission	  wavelength	  +	  50	  -­‐	  100	  nm	  or	  larger.	  The	  integration	  was	  set	  to	  1	  s,	  and	  for	  high	  quality	  scan	  the	  average	  was	  set	  to	  2:	  the	  system	  repeat	  two	  times	  the	  measurement	  and	  average	  the	  readings.	  The	  excitation	  scans	  were	  acquired	  inserting	  a	  range	  of	  acquisition	  for	  the	  excitation	  (ie.	  for	  YPet	  450-­‐525)	  and	  the	  exact	  value	  of	  emission	  of	  the	  protein	  for	  the	  emission.	  Finally	  the	  fluorescent	  proteins	  encapsulated	  in	  w/o	  emulsion	  were	  visualized	  using	  a	  Nikon	  Eclipse	  90i	  microscope	  with	  a	  Nikon	  DS-­‐5MC	  camera	  and	  a	  FITC	  filter	  FITC	  with	  an	  excitation	  	  of	  465	  -­‐	  495	  nm	  	  and	  an	  emission	  of	  	  515	  -­‐	  555	  nm.	  The	  magnification	  used	  for	  collect	  the	  images	  is	  40X.	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  Chapter	  5	  
	  
Conclusions	  and	  future	  directions	  	  5.1	  Conclusions.	  	   This	   dissertation	   offers	   new	   routes	   towards	   the	  design	   of	   artificial	   cells	  and	   proposes	   new	   possible	   approaches	   for	   the	   reconstruction	   of	   cell	   body	  division	  in	  cell-­‐like	  compartments.	  	  	  	  
  Cell-­‐like	  compartments	  hosting	  purified	  proteins	  from	  E.	  coli	  cell	  division	  machinery	  system,	  although	  show	  typical	  features	  of	  cell	  division	  are	  not	  able	  to	  divide,	  as	  demonstrated	  in	  chapter	  4.	  A	  “simple”	  encapsulation	  of	  purified	  proteins	  in	  w/o	  emulsions	  does	  not	  result	  in	  a	  living	  system.67,68	  	  In	  fact	  a	  system	  like	  that,	  is	  not	  only	  incapable	  of	  division	  but	  is	  also	  not	  self	  sustainable.	  Towards	  the	  development	  of	  a	  genetically	  encoded	  system,	  synthesizing	  a	  minimal	  division	  machinery	  directly	  inside	  w/	  o	  emulsions	  and	  phospholipid	  vesicles,we	  made	  a	  step	  forward	  through	  the	  construction	  of	  an	  artificial	  minimal	  cell.	  Our	  system,	  described	  in	  chapter	  3,	  is	  capable	  of	  transcription	  and	  translation	  of	  the	  DNA	  in	  fuctional	  proteins	  of	  the	  divisome	  such	  as	  FtsZ	  and	  FtsA	  and	  although	  is	  not	  able	  to	  divide,	  it	  is	  such	  a	  system	  come	  closer	  to	  the	  criterion	  of	  autopoiesis9,	  an	  essential	  feature	  of	  cellular	  life.	  We	  provided	  a	  possible	  strategy	  for	  the	  fine	  control	  of	  the	  protein	  production,	  engineering	  constructs	  under	  the	  control	  of	  strong	  RBS	  sites	  and	  envisioning	  a	  possible	  modulation	  of	  the	  strength	  for	  the	  reproduction	  of	  a	  ratio	  of	  4:1	  for	  FtsZ	  and	  FtsA.	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Furthermore	  FtsZ	  and	  FtsA,	  once	  produced	  in	  the	  compartments,	  show	  an	  unusual	  behavior,	  assembling	   together	  and	   	   forming	  ring-­‐like	  structure.	  This	   is	  another	   cellular	   imitation	   that	   we	   were	   able	   to	   reproduce	   in	   our	   synthetic	  minimal	   cell.	  As	   in	  vivo	  where	   the	  Z	   ring,	  made	  of	  FtsZ	   subunits	   interacts	  with	  FtsA	  and	  localize	  in	  proximity	  of	  the	  membrane,	  in	  cell	  like	  compartments	  YFP-­‐FtsZ	   interacts	   with	   FtsA	   and	   direct	   itself	   to	   the	   membrane.	   Definitively	   the	  reconstruction	   of	   a	   primitive	   event	   of	   cell	   division	   was	   possible.	   The	   round	  shape,	  of	  the	  liposomes	  and	  of	  w/o	  emulsions	  does	  not	  help	  the	  generation	  of	  the	  constriction	  force	  and	  does	  not	  permit	  a	  spatial	  localization	  of	  the	  proteins.	  	   For	   this	   reason	  we	  developed	  and	  characterize	  w/o	  emulsion	  ATPS	  and	  w/o	   emulsions	   A3PS	   compartment	   that	   present	   an	   internal	  compartmentalization	  optimal	  for	  the	  spatial	  localization	  of	  the	  proteins	  of	  	  our	  system.	   The	   reconstruction	   of	   a	   genetically	   encoded	   system	   in	   these	  compartments	   is	  possible,	  as	  demonstrated	  by	  the	  expression	  of	  YFP/YPEt	  and	  we	  can	  spatially	  localize	  the	  protein	  produced.	  Furthermore	  w/o	  emulsion	  ATPS	  have	  a	  budding	  morphology	  and	  undergoes	  to	  chemical	  division	  when	  fed	  	  with	  micelles	   of	   SDS.	   These	   features	   are	   useful	   for	   the	   reconstruction	   of	   cell	   body	  division	  mechanism.	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5.2	  Future	  directions.	  	  	  	  The	   next	   step	   in	   this	   work	   is	   to	   encapsulate	   the	   genetically	   encoded	  system	   for	   the	   synthesis	   of	   FtsZ	   and	   FtsA,	   in	   w/o	   emulsions	   ATPS	   and	   w/o	  emulsions	  A3PS.	  This	  combination	  will	  result	   in	  an	  artificial	  cell	  provided	  of	  an	  internal	   compartmentalization	   and	   potentially	   able	   of	   division.	   If	   the	   artificial	  cell	   will	   not	   be	   able	   to	   divide,	   will	   be	   at	   least	   capable	   of	   spatially	   localize	   the	  proteins	  and	  the	  ring-­‐like	  structures	  formed	  by	  FtsZ	  and	  FtsA.	  Another	  possible	  and	  challenging	  future	  direction,	  that	  could	  represent	  another	  step	  towards	  the	  	  construction	  of	  artificial	  cell,	  could	  be	  the	  encapsulation	  of	  a	  genetically	  encoded	  system	  	  for	  	  FtsZ	  and	  FtsA	  in	  GVs/ATPS	  	  Furthermore	   is	   possible	   that	   ATPS	   w/o	   emulsions	   and	   A3PS	   w/o	  emulsions	   could	   be	   used	   as	   novel	   systems	   for	   delivery,	   not	   only	   of	   chemical	  drugs	  but	  also	  of	  proteins,	  genes	  and	  why	  not	  of	  elementary	  molecules.	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Appendix	  	  	  	  	   	  
Fig	  A.1:	  Optimization	  of	  	  overlapping	  PCR.	  Trying	  to	  obtain	  less	  aspecific	  bands,	  using	  as	  annealing	  temperature	  the	  melting	  temperature	  of	  the	  overlapping	  region	  in	  the	  forward	  primer	  +3°C,	  as	  the	  protocol	  for	  Phusion	  High	  Fidelity	  DNA	  Polymerase	  forecasts.	  The	  resulting	  annealing	  temperature	  is	  	  63.8	  °C.	  The	  reaction	  of	  extension	  and	  overlap	  is	  carried	  on	  by	  Phusion	  High	  Fidelity	  DNA	  Polymerase	  in	  HF	  buffer.	  The	  length	  of	  sfgfp-­‐ftsA	  is	  1983bp.	  The	  ladder	  used,	  is	  a	  	  1	  kb	  ladder	  	  (Fermentas).	  	  	  	  	   	  
Fig.	  A2:	  Overlapping	  PCR.	  Trial	  to	  obtain	  	  an	  higher	  amount	  of	  	  the	  band	  correspondent	  to	  
sgfp-­‐ftsA.The	  DNA	  was	  overlapped	  and	  extendend	  by	  a	  mixture	  of	  Taq	  and	  Phusion	  High	  Fidelity	  DNA	  polymerases	  (1.5	  U	  of	  Taqand	  0.5	  U	  of	  Phusion).The	  length	  of	  the	  gene	  is	  1983	  bp.The	  problem	  of	  aspecific	  bands	  still	  persist,	  but	  the	  amount	  of	  sgfp-­‐ftsA	  produced	  is	  higher.	  The	  program	  used	  for	  the	  reaction,	  forcasts,	  melting	  and	  denaturation	  temperature	  at	  95°	  for	  2	  min,	  anneling	  at	  60°C	  for	  30	  min	  and	  extension	  at	  72	  °C	  	  for	  2	  min.	  The	  program	  was	  stopped	  and	  the	  polymerases	  were	  added.The	  program	  was	  repeated	  for	  25	  times,	  and	  a	  final	  extension	  at	  72	  °C	  for	  10	  min	  was	  performed.	  Lane	  A	  corresponds	  to	  a	  reaction	  performed	  with	  100	  ng	  of	  DNA	  template,	  lane	  B	  to	  a	  reaction	  with	  50	  ng	  and	  lane	  D	  corresponds	  to	  a	  reaction	  with	  25	  ng.	  The	  ladder	  used	  is	  1kb	  (Fermentas).	  	  	  	  	  	  	  
	  	  	  3000	  bp 
       1983	  bp 
A 	  B 	  C D 
	  	   92	  
Table	  A1:	  List	  of	  the	  primers	  used	  for	  the	  genetic	  constructs.	  	  	  	  
CONSTRUCT	   PRIMER	  
PRIMER	  	  
SEQUENCE	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5’	  –	  3’	  
Tm	   Length	  (bp)	  
FtsZ-­‐YFP-­‐MinD	   Primer	  1	  (fwd)	   CCCGGCCCATATGGGCAGCTCT	   66.2°C 22	  Primer	  2	  	  (rev)	   CGCGCGCCTCGAGTTAACCGCC	   67.4°C	   22	  
YFP-­‐FtsZ	   Primer	  1	  (fwd)	   CCCGGGCCATATGGGCAGCCACCAT	   69.3	  °C	   25	  Primer	  2	  	  (rev)	   CCGGCCGGATCCTTATCAGTCGGC	  TTG	   66.1	  °C	   27	  
CFP-­‐FtsA	   Primer	  1	  (fwd)	   GGCCGGCCCATATGGGCTCACATCAT	   67.5	  °C	   28	  Primer	  2	  	  (rev)	   CCCGGGCGGGATCCTTATCAAAATTCT	  TTACG	   62.3	  °C	   29	  
CFP-­‐R286W	  	  FtsA	   Primer	  1	  (fwd)	   GGCCGGCCCATATGGGCTCACATCAT	   67.5	  °C	   28	  Primer	  2	  	  (rev)	   CCCGGGCGGGATCCTATCAAAATTCT	  TTACG	   62.3	  °C	   29	  
sGFP-­‐GSGSGS-­‐FtsA	  
Primer	  1	  (fwd)	   GCAGCAGGCCCATGGATGCGTAAAGGCGAAGAGCT	   70.7	  	  °C	   35	  Primer	  2	  	  (rev)	   CGGGGCGGATCCGT	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ACCAGAGCCTTTGA	  	  	  	  CAGTTCATCCATACC	   70.5	  	  °C	   45	  Primer	  3	  (fwd)	   GCAGCAGGATCC	  ATGATCAAGGCGACGGACAG	   67.6°C	   32	  Primer	  4	  	  (rev)	   CGGCGGCTCGAGTTACTCTTTTCGCAGCCAACTATT	   67.3°C	   36	  
FtsZ-­‐YFP-­‐MinD-­‐FtsA	  
Primer	  1	  (fwd)	   GCAGCACATATGTTCGAACCGATGGAACT	   62.3°C	   29	  Primer	  2	  	  (rev)	   TAATATGAGCTCTTA	  ACCGCCGAACAGACGT	   62.1°C	   31	  Primer	  3	  	  (fwd)	   GACGACAAGCTT	  AAGGAGAGCTAGCTATGATCAAAGCTACGGACCG	   67.1°C	   46	  
Primer	  4	  	  (rev)	   CGCCGCCTCGAGTTA	  TCAAAATTCTTTACG	  CAGCC	   65.8°C	   35	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CONSTRUCT	   PRIMER	  
PRIMER	  	  
SEQUENCE	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5’	  –	  3’	  
Tm	   Length	  (bp)	  
FtsZ-­‐YFP-­‐MinD-­‐R286W	  FtsA	  
Primer	  1	  (fwd)	   GCAGCACATATGTTCGAACCGATGGAACT	   62.3°C 29	  Primer	  2	  	  (rev)	   TAATATGAGCTCTTA	  ACCGCCGAACAGACGT	   62.1°C	   31	  Primer	  3	  (fwd)	   GACGACAAGCTT	  AAGGAGAGCTAGCTATGATCAAAGCTACGGACCG	   67.1°C	   46	  Primer	  4	  (rev)	   CGCCGCCTCGAGTTA	  TCAAAATTCTTTACG	  CAGCC	   65.8°C	   35	  
YFP-­‐FtsZ-­‐FtsA	  
Primer	  1	  (fwd)	   GCAGCACATATGGTGTCCAAAGGCGAAGAACTG	   65°C	   33	  Primer	  2	  	  (rev)	   GGC	  GGC	  GAG	  CTC	  TTA	  TCA	  GTC	  GGC	  TTG	  TTT	  AC	   66.1°C	   32	  
Primer	  3	  (fwd)	   GAAGAAGTCGAC	  AAGGAGAGCTAGCT	  ATGATCAAAGCTACGGACCG	   67°C	   46	  Primer	  4	  (rev)	   CGCCGCCTCGAGTTA	  TCAAAATTCTTTACGCAGCC	   65.8°C	   35	  
FtsZ	  (	  no	  His	  tag)	   Primer	  1	  (fwd)	   GCGGACCATATGGAACTGACCAATGATGC	   62.8°C	   29	  Primer	  2	  	  (rev)	   TGCTGCCTCGAGTTA	  TCA	  GTC	  GGC	  TTG	  TTTAC	   64.2	   32	  
	  FtsA	  (no	  His	  tag)	  
Primer	  1	  (fwd)	   GCGGACCATATG	  GAACTGACCAATGATGC	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  63.7°C	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  29	  
Primer	  2	  	  (rev)	   CGCCGCCTCGAGTTA	  TCAAAATTCTTTACG	  CAGCC	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  64.6°C	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  35	  
Table	  A1:	  In	  this	  table	  are	  listed	  the	  sequences	  of	  the	  primers	  designed	  for	  our	  genetic	  constructs	  the	  length	  and	  the	  melting	  temperature	  (Tm).	  In	  different	  colours	  are	  highlighted	  part	  of	  the	  sequence	  correspondent	  to	  restriction	  enzymes	  sites.	  In	  the	  single	  construct	  CATATG	  highlighted	  in	  red	  is	  the	  site	  correspondent	  to	  NdEI,	  CTCGAG	  highlighted	  in	  orange	  is	  the	  site	  correspondent	  to	  XhoI	  and	  finally	  GGATCC	  highlighted	  in	  blu	  is	  the	  site	  correspondent	  to	  BamHI.	  In	  the	  double	  construct	  CCATGG	  highlighted	  in	  violet	  is	  the	  site	  for	  NcoI,	  GAG	  CTC	  highlighted	  in	  purple	  is	  the	  site	  for	  SacI,	  AAGCTT	  highlighted	  in	  green	  is	  the	  site	  for	  HindIII,	  GCTAGC	  highlighted	  in	  cyan	  is	  the	  site	  for	  NheI,	  GTCGAC	  highlighted	  in	  grey	  is	  the	  site	  for	  SalI.	  In	  black	  is	  highlighted	  the	  consensus	  sequence	  of	  the	  RBS.	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Fig	   A4:	   YFP-­‐FtsZ	   (MW:	   70.2kDa).	   Lane	   A	   is	   the	   fraction	   from	   the	   washing	   with	   just	   binding	  buffer.	   Lane	  B	   is	   the	   fraction	   from	   the	  washing	  with	   60	  mM	   imidazole.Lane	   from	  C	   –F	   are	   the	  fractions	  deriving	  from	  the	  elution	  with	  255mM	  imidazole.	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